.. 
(List of Hospital Formulary A.D. 2006)

-. /012/0 -0 3456789

:;<
=>403456 .. ? (@

A>; )

12/0 -0 3456789

ISBN : 978-974-244-233-0
2
3
74
 ()


 


  !"
 #. . %&'( ()*! &)



 *! %/%&'(   !"
 #. . %&'( ",*!
%% #- .
 #. . %&'( 

/
 !"

#
0,*1


2344
* *,56
"!
*27#8 !89,

3
/4 !"
1,4

7:#""
45#" 

.6


 /
!8
;. 1 
"

7      :#"1 !  *  




*! %/%&'( ",*! %% #- .
 #. . %&'( "11

7:#" *!*

 !8
%. 1 
"

14  <.= "#  4  <.> 1
"3   <
Respiratory system 1 !"
 *!*

 


*! %/%&'( ",  *! %% #- .
 #. .%&'( "1 1   
4
"3   <
Respiratory system *!*

 !8
<. 1
"

14 (.'.< 44 (.' 1
"3 ( Obstetrics,
gynaecology, and urinary-tract disorders 1 !"
 *!*




     *! %/%&'( ",  *! %% #- .
 #. .%&'( "1


 

*! ;/%&'T ",*! %( 
 #. .%&'T "11


4
"3 ( Obstetrics, gynaecology, and urinary-tract disorders *!*


 !8
'. 1#4 ;U.< 1
"3 ;U Musculoskeletal and joint diseases
1 !"
 *!*

 

*! %/%&'( ",*!
%% #- .
 #. .%&'( "11
4
"3 ;U Musculoskeletal and joint
diseases *!*

 !8

 &. 1
"

14 ;;.;.; 44 ;;.; 1
"3 ;; Eye 1
 !"
 *!*

 

*! %/%&'( ",*!
%% #- .
 #. .%&'( "11
4
"3 ;; Eye *!*

 !8
=. 1
"

14 ;%.; "4 ;%.<.; 44 ;%.< 1
"3
 ;% Ear, nose and oropharynx 1 !"
 *!*

 


*! %/%&'( ",*! %% #- .
 #. .%&'( "11
4
"3
 ;% Ear, nose, and oropharynx *!*

 !8

*8!88!8
0/


  ,*! <U #- .
 #. . %&'T
(") "  4"
("  4")
\!,

*,234

2



4

74




 


     .. (  !" ) !$ %  &'(  ) !
'
  .. 
!

*+,'!"'  % - ./
0. ) !  %1   2''%3
%4 %5+
!
,'!" '
61- 7 
 ./
0.0
!
,"
+8$  
 *
Opium and Glycyrrhiza Mixture
Compound, Aromatic Ammonia Spirit, Sodium citrate and citric acid oral solution,
Methyl Salicylate Cream Compound, Methyl Salicylate Ointment Compound, Sodium
bicarbonate ear drop ' lodine Paint, Compound
0.
!
 !"//
0 
 *
Silver nitrate eye drop ,."/6

/6*
'/U  
6 
! '
V.  % 4& '+/!$ ( gonococcal ophthalmia
neonatorum  (%U/
/, , *  1(,

,+/%'' Silver
nitrate *  1(-
,+
++/,"
+8$% &'(,
 chemical conjunctivitis
!

,./ !",."/Y8"
-

/,Z+/ 

,
 (38 0 ,./) '/6
/* 38 
- 6
!
[ /
 (,." /
,
Z 
\' -
Z -
*

'/U+/
' -(, * /] /
6
!$ WHO Model List 2005 *!$//

, 

. 
,U%12'

!&'(
,U%12' ..  ,d/
,'
*'(

,U%12' .. e  

....

+

74





(1) 
  



 


! 


"..2547 (() 5)
(2) *
+,

(3) .


(4) /.*
0
"

!1

! 

))


  



 


! 


".. 2547 (() 5)
.2) 1 
.*
0
"

!!.3

.
4
 .51 2
.2) 2 

/.*
0
"

! 8
)) 1 
!
 ! 78
! 

/.*
0
"

!
1. 22
9
8
2. ).*
1

,)*
:/.*
0
"

! ".. 2549 10
=
! 

 ".. 2547>
3. 
!!
 11
4. 2)

!!  78=
! 11
5. 2)


25 *
5 /
"
)?!=0
"

! 12
6.  78,4 12
)) 2 

/.*
0
"

! ".. 2549
2.1 .A*

1
/.*
0
"

!
Creams
Betamethasone Dipropionate Cream 14
Betamethasone Valerate Cream 14
Hydrocortisone Acetate Cream 14
Methyl Salicylate Cream Compound 14
Prednisolone Cream 15


 Sulfadiazine Silver (Silver Sulfadiazine) Cream 15
Triamcinolone Acetonide Cream 16
Urea Cream 16
Ear Drops
Sodium Bicarbonate Ear Drop 16
Elixirs
Potassium Chloride Elixir 16
Lotions
Benzyl Benzoate Lotion 17
Calamine Lotion 17
Salicylic Acid Lotion 17
Triamcinolone Acetonide Lotion 18
Zinc Sulfate Lotion 18
Mixtures
Ammonium Carbonate and Senega Mixture 18
Compound Cardamom Mixture 19
Magnesium Sulfate Mixture 19
Opium and Glycyrrhiza Mixture Compound 20
Squill and Ammonia Mixture 20
Nasal Drops
Ephedrine Hydrochloride Nasal Drop 20
Ointments
Benzoic Acid and Salicylic Acid Ointment 21
Coal Tar Ointment 21
Dithranol (Anthralin) Oinment 21
Methyl Salicylate Ointment Compound 21

,
 Nitrofural (Nitrofurazone) Ointment 22
Salicylic Acid Ointment 22
Sulfur (Sulphur) Ointment 22
Urea Ointment 23
Paints
lodine Paint , Compound 23
Podophyllin Paint (Podophyllum Resin) 23
Pastes
Salicylic Acid Paste 23
Zinc Oxide Paste 24
Powders
Macrogol Oral Powder 24
Oral Rehydration Salts 24
Scrubs
Povidone-Iodine Scrub 25
Shampoos
Tar Shampoo 25
Solutions
Aluminium Acetate Solution (Aluminium Subacetate) 26
Cloral Hydrate Oral Solution 27
Copper Sulfate Sterile Solution 27
Ethyl Alcohol Solution 27
Glycerol Oral Solution 28
Intraperitoneal Dialysis Solution (Isotonic Solution)(1.5% Dextrose 28
in Dialysis)
Intraperitoneal Dialysis Solution (2.5% Dextrose in Dialysis) 28

(
 Intraperitoneal Dialysis Solution (4.25% Dextrose in Dialysis) 28
Lugolps Solution 29
Magnesium Sulfate Solution 29
Neutral Phosphate Oral Solution 29
Potassium Acetate Sterile Solution 30
Potassium Citrate Oral Solution 30
Povidone-Iodine Solution 30
Saturated Solution of Potassium Iodide Oral Solution (SSKI) 31
Sodium Acetate Sterile Solution 31
Sodium Citrate and Citric Acid Oral Solution 31
Sodium Citrate and Potassium Citrate Oral Solution 32
Sodium Thiosulfate Solution 32
Tincture of lodine Solution (lodine in Alcohol) 32
Trace Element Solution (Oral Solution) 33
Zinc Sulfate Sterile Solution 33
Spirits
Aromatic Ammonia Spirit 33
Suspensions
Aluminium Hydroxide and Magnesium Hydroxide Suspension 34
Aluminium Hydroxide Suspension 34
Bentonite Magma Suspension 35
Magnesium Hydroxide Suspension 35
Mebendazole Suspension 35
Syrups
Acetaminophen (Paracetamol) Syrup 36
Chlorpheniramine Maleate Syrup 37


 Ferrous Sulfate Drops 37
Glyceryl Guaiacolate Syrup 37
Potassium Chloride Syrup 38
Tinctures
Thiomersal (Thimerosal) Tincture 38
Dental Preparations
Artificial Saliva Solution (Saliva Substitutes) 39
Camphorated Parachlorophenol Solution 39
Camphorated Phenol Solution 40
Carnoyps Solution 40
EDTA Solution 40
Fluocinolone Acetonide Gel 41
Fluocinolone Acetonide Solution 41
Formaldehyde and Cresol Solution 42
Talbotps Solution 42
Whiteheadps Varnish 43
Zinc Oxide and Zinc Acetate Powder 43
2.2 .A*
1
.
2=/.*
0
"

!
Cream Bases
Non-ionic Buffered Cream Base 43
Ointment Bases
Hydrophillic Ointment Base 44
Preservatives
Paraben Conc 44

r
)) 3 !  7824
) =
?!
=0
"

!
3.1 !  7824
)=
?!
)v=

,
+= 45
0
"

!
3.2 !  7824
)=
?!
"w("

= 57
0
"

!
3.3 !  7824
)=
.


)

!!*
.*
 64
?Ax2("

=0
"

!
3.4 !  7824
)=

)"wr!!8.*
?Ax2 67
("

=0
"

!
3.5 !  7824
)=
?!

=0
"

! 73
3.6 !  7824
)=
?!
,
.5v"=0
"

! 78

5  82
(5) /
?2
2

25
?!
(Compounding Card) 84
2

+*
.

"="

"w("

 85
2

2
11 A +*
.

)! = 2.+
5 86
!24
 y w
1

"w("


2

.
z
.)==

87
.
 

"
 .2 1
.
=*

88
!
1A!
)!

=0
"

! 89


 )*


,)*
/.*
0
"

! 90

u

74

 

 

 

 
! "#$%&


! " .. 2547 (.

 5)

%& 0


 $ %&1

!  3 Respiratory system



3.6 Cough preparations
3.6.1 Cough suppressants
1. Dextromethorphan hydrobromide tab, syr 
2. Opium and Glycyrrhiza Mixture mixt (hosp) 
Compound (Brown Mixture; Mist.
Tussis)
3. Squill and Ammonia Mixture mixt (hosp) 
4. Codeine phosphate tab , -./01-23 0/1452678-9
:;<=>?1@; 2
3.6.2 Expectorant and demulcent cough preparations
1. Ammonium Carbonate and mixt (hosp) 
Senega Mixture
2. Glyceryl guaiacolate tab, syr 



3.8 Other respiratory preparations
1. Aromatic Ammonia Spirit spirit (hosp) 

1
 %& 0


 $ %&1
!  7 Obstetrics, gynaecology, and urinary-tract disorders



7.4 Drugs for genito-urinary disorders



7.4.3 Drugs used in alkalinisation of urine
1. Potassium citrate oral sol (hosp), 
dry pwdr for
oral sol (hosp)
2. Sodium citrate + Potassium citrate oral sol (hosp) 
3. Sodium citrate and citric acid oral sol (hosp) 
(ShohlEs Solution)



!  10 Musculoskeletal and joint diseases



10.3 Drugs for relief of soft-tissue inflammation
10.3.1 Rubifacients
1. Methyl Salicylate Cream cream (hosp) 
Compound
2. Methyl Salicylate Ointment ointment 
Compound (Analgesic Balm) (hosp)



2
 %& 0


 $ %&1
!  11 Eye
11.1 Anti-infective eye preparations
11.1.1 Antibacterials and eye wash solution
1. Boric acid eye wash solution 
2. Chloramphenicol eye drop, eye oint 
3. Tetracycline eye oint 
hydrochloride
4. Polymyxin B sulfate + eye drop G
Neomycin sulfate+
Gramicidin
5. Fusidic acid eye drop (in gel , -./01-23 0/1=JK0L1=ML
base) GNO1-P1.QKN0/4R.SR4TU2/
6. Tobramycin eye drop, eye oint O 8W91=ML0/X;L (Alternative
drug) 4Z/->R[/>2671WQ\N
>3LX>O=/L/O;JK2/ ->QN1.QKN
X59 polymyxin ->QN neomycin



!  12 Ear, nose and oropharynx
12.1 Drugs acting on the ear
1. Chloramphenicol ear drop 
2. Sodium bicarbonate ear drop (hosp) 
3. Dexamethasone + ear drop/oint (1^5/? ,
Framycetin sulfate + 0.5 mg + 5 mg + 0.05
Gramicidin mg in 1 ml or 1 g)
4. Polymyxin B sulfate + ear drop (1^5/? ,
Neomycin sulfate + 10000 U + 3400 U +
Hydrocortisone 10 mg in 1 ml)

3
 %& 0


 $ %&1
5. Ofloxacin ear drop O 8W94Z/->R[-UL\Z/-LP;J7K Q\N2bN
chloramphenicol
-./01-23 ,P>.J guideline
;JKWR71cL8L/>Z/R[/>8W9
0/LJ\ 15>/?/>8W90/N/c
4bOS8-9167=de-/1WQ\N7Q\N
2bN0/3b. quinolones



12.3 Drugs acting on the oropharynx
12.3.1 Oropharygeal antiseptics
1. Borax (in glycerin) sol 
2. Camphorated sol (hosp) 
parachlorophenol
3. Camphorated phenol sol (hosp) 
4. Chlorhexidine gluconate mouthwash sol 
5. Formaldehyde + Cresol sol (hosp) 
(Formocresol, Cresolated
Formaldehyde)
6. Hydrogen peroxide mouthwash sol 
(1.5%w/v),
sol (1.5%w/v,30%w/v)
7. Iodine Paint, Compound paint (hosp) 
(MandlEs Paint)

4
 %& 0


 $ %&1
8. TalbotEs Solution sol (hosp) 
(Iodine and Zinc Iodide Glycerite)
9. Iodoform (in ether) sol (hosp) G



5
6
74

 
  



  !" # $
%
 . . 2547 (,

 5)

 1    
"/0 !$
% 
 
  


   
  
 (Hospital Preparations) ! "#$% & '()*
!+,%*-

- .'!  

$!!
*!/!0.1!- 21 2*-

+ -3%41560 
271
58*95+100.5 :7+ ;(.#0.<
58*!/&$/!- ;+7,:
&7 ;+- 2*
:

= >? '
    

  

58 *
!- - 3>@    < 2*- ($  *
!'!
  
'!  A 2*.5 :
"B )  ,/  .    -"#$ 5 D($  2*/ 0 , -  E *.;-
Galenical preparation
 
 B& &  
 (
 
 
#* , ")

 
  
;?H- >@
 
- .- , "@ ,:
 
I

- :" 0
= >?' .B. 2519
- :" 0= >?'9+1*/!- E*+
;? -
 
  

(Hospital Preparations)
'1901
58*/0*7*($'!
<#7-,7/& .B. 2524 D($
58*
<#
7-,7/&I

, - /!..#- "
"0*5 
5 ?!//!
*$!;*O( P
<#7-,7/&
.B. 2542Q 7 

<#7-,7/& .B. 2547 9+15 

5 ?,:,-
/.
58* 1
 

  
 . . 25493
$!/
 &.- 21B @,:B&5:2*- 5 ?%. 

 #.
"#$;
58*1!
 #.212*  
 0
4/-
- !*00.:+0-2*-
&7 

1.  4!4#
5#
- , "@,

? 52*.5 :
"B,/
+&.*)* , "@.&9+1.#7*1"#$
I :-  0;

0&*&;I ,: -3%41560,/1!"7*1"#$5 ?+10 2*. -"#$ 6 6# #
$76

689 #4 :";  <1 (
*=&- "7
- 2*'>:*)*) "  :+ &0/
P....- .-!"7
-.#, "@5 :;7*/0 
!4/,10 ,/9./.#%41"#$9+1
#* ,:9+1 

- !
.955 :;."#$;/
 0 ) 
#*, "@5 ?'()*!#-,'*7*($...Q :
;1
*1!
=!  #;
 (%41
<-  
#* , " B'>:*)*) 9+1

1
5 :&
5/0&"
- .,7/- ? *-&*" @ 2* !
200 5U. 2526.
1
*/! :+ & -/0! 271;+) 
#*, "@5 ?'()* +.#- !*0& -A* /0.95
-
* -
#  *, "@ ,1 0 95,--* "V6  , "@ 5 ?  271 95
#  *
 B @ ,:VW - 7 +
"
- . ,10"7*1"#$
58*, "@5 ?/!95 ;*- :"$
.$!0*;*" @"#$ 8 =*0.
2456
;1 : :
+Y; (
*
+#- :" 0= .- 2*'>:*)*) 9+15 :-B P :

#
- ;+
*-
#*, "@%. .B 2457Q (
5Z+
#* 0*! "#$ 2 .&O?** .B 2457) .#*-
#*
, "@'!!*.
#* ?/*, - 4 * - O5*0&#
- .,%*:0*-2*5 :
"B
. ;(
-&+),/
+*)*
"
"7*1"#$2*- 5 ?7 !%&+-/09+1 E*.!/
/ !
*$ ! ;*O(  5[ ; ;?
 * 0-
  - .;( 
"& + "4 * ")  ! :!@
58 *
? - # ' !0&  #

- .,%*5[;;?
*,7/5 :
"B9"
2*/ 0 , - *
  - .
&$ . '() * "#$ ,%*-5 ?   B& &  
 - ., "@
"7
- -!!OB - .= >?' ,10'4/  
!$*\ +.?/
*1*- 21
B @,:B&5:2*- 5 ?%. (science and art of compounding) ,:-
&7 
 (medical depot)
58*7- 2*5[;;?
*9+1.#- '
"
"954/- ?1. !%41560,:
%41
&,:%&>b@?' -/0! -
&- ;7*/0
4/95-
-
&- 271
,*:*+1*,:?' 0.O( - '
"
";--
 #.,-/%41560
I : 
4/- %&2*')*!?7- ."#$.#- 5 :-*?> ,:0.5!+!/
58* :

.
7-
->b@,:0&=#- "#$+#2*- %& *!-;-*)* 9+1.#- 5 

5#$*- :
0*"B*@;-- !

+1*
"*#- %&"#$.#%&>b@
58*B4*@-954/- .#%41560
58*B4*@-
&$.'()*

;(/%271
-&+- E*
"
"+1*
- .&*&- ,:/!
*$!.4/,*0&+-
&
"

- . !/9 -Y. ,.1;:.#,*0&+2*- .?/271%41560
58*B4*@-.-'()* ,/
"
"
2*- 5 ?-Y
58*
"
"<'!*
- .  
 +
I :
"
"-

 #.,:%.7 
%41560
I : "#$2*5[;;?
*.#
"
"
&$.'()*!//!
*$!
- :" 0= >?' 9+121
 
'!  
2* -+.70& ",:

 
'!/5 :
"B
58*4/.!2*- 5 ?.!//!
*$! ;*- :"$ 5U .B. 2506
*, "@V* ,&,-10 !=&
+#- .- , "@ 2*.*)* D($"7*1"#$--
+4,  
2*
-+- :" 0= >?'"?-,7/ 9+1
Y
7Y*0.<2*- +
!-,:%&"#$.#0.
;
58*/!?' ;(271;+" P
 
I

- .- , "@Q '()*
58* ), - +>; @
'!>:
B @ , "@,:
- '!- .- , "@ 9+1 /0.-*+
*&*- ;*,10
 Y;

2
,:
&$.21 ), -
.$! .B. 2506 /!.5U .B. 2515 .#- 5 
5 ?  1'!- :" 0
= >?' - ;+"
 
'!  
;(
5#$*.!4/2*0. 
%&+!
'!-!
  
4.& *-*5+- :" 0= >?' D($+
*&*- 5 
5 ?/!
*$!
58*

 
,

  4= "; > . . 2519
$!271  
2*-+21
58*
,./,

2*- +
!-,:5 ?901212*  


 
I

*#)5 :-!
+10 4 
D($2* P"#$ 2 Hospital PreparationsQ
58* 

 #."#$0
 #.901212*  

;,*-.5 :
"'!-
 #."
- .
#.0!-3 9+1,-/ 5 :
""$095
5 :
"
+Y- 5 :
"c[* ,:*)"+!
(Reagent) 
 #.,/: - .# :
!#+"#$

-#$0'1!/ \ 901+10 -/0! $! 1! (synonyms) -?/. (category) '*+ (dose) -

-Y
 - 3 (storage) ,:'1 !  
-!$ * \ '!,/  :  
/ ! .9+1 .# -  * 
    

  
.
;?9012*
<#7-,7/& .B.2524 ,:.#- E*5 
5 ?
$!.
;*O(
<#7-,7/& .B. 2542

2.

!  6 $ 1
  
  
 . . 2549 ?
   
 . . 25473

2*5[;;?
* !?7- .- %& :+
-.#- E*
"*#"
- .
!/.- *!-;-*)* - 1
 # ,: :

&"=&
 9+1/%271.#- ,'/-*%&27./"#$.#
0.7-7,: , .-'()* /0*!?7- .- 2*5 :
"B-Y.#- E*+1*
. A*- %&271
58*95.7-
->b@,:0&=#- "#$+#2*- %&"#$
58*"#$!. 
2*
:+
- .#- ,'/'*-*%&$!.<.-'()* -!5 -
- :" 0= >?'9+1.#-
5f& 4 5 :

-
& 7 
0 > b@ .# -  ; + D) !  / 0 .- * 2* :+
/  \ /  %271 '!
%&>b@$!.<+
58*+
!/9 -Y. .#
 - "#$.#0.;
58*1!21
2*%41560*1!  7 !219./.- .#+;-+ =? -&;
!-*-Y-
&-- %& *
'1 7 !
;7*/ "271  
,:O*
&- = >?''+,*;
58*"#$1!21-
%41560
+  *) * ;(  ; 
58 * 1 ! */ ! ,:/ 
 & .  E *- 5 ?  7 !-
 #  .
$ ! 21
!2*
  
!//!
*$!
$!- ($*
!2* :+
7*($ +.?/
*1*- %&;
58* )*A*
- 1 7 ! - "#$1!.#- 5 :?-@;+
 #.271%41560
I :  D($  
/0*
27</.#B- 2*- +
*&*-
 #. 5 ? 7 !%&;
58*+-/0!4/,10 0
4/-
-

3
 -3B @,:B&5:,7/- 5 ?D($
58* -A*'!*
- . ,:/
 &.- %&
;-.?*9 "#$
58*4.&5[<<'!5 :
"B9"
95
2*- ;+"
<#7-,7/& .B. 2547 >:!*?- .- E*
<#7-
,7/& 9+1
Y
7Y*0.<2*- %&
$!- ($ *
!,:!
*!/!0.
1!- 21'!  
*)* \ 271
58*95+100.5 :7+ ;(9+1,/) !"
6 $  
    
  
 '() *
.$ ! 0 * "#$ 14 - -g. 2548
$ ! & ;  >"
"0*
5 
5 ? ;+" - '()*
58*
 
  
 . . 2549 ?

 . . 2547 271.#0."*.,:
7.:.-
0- >@5[;;?
*/!95

3.  
-
   
  
2*
< # 7 -,7/ & ; + " '()*
$ ! *
*? *
/
 &.271  
/ \ ($*
!9+12*+1* .0.;
58*2*- 5h!-*,:,-19'
5[<7?' . O271
&- 9+1!//!
*$! "*O*- >@ + !
?.O(-
 #.
"#$ 2 1
 
 +  ,:!-
;Y
56 0 

) ! 1 * -  1  
 4 5 ,

"#$ 9 ./ .# ;  7*/  2*

"1!+ "#$0 %.21"*"# 
 #.7 
%41560
I : 
/* 
.#

+  !7
"#$271"7!+
!++
58*1* 0.") 
 #.;-.?*9 + 
"#$9+1 
- +
!-
;:1!.#0.5!+ .#5 :&"=&% *!-;-*)*   
1!.#B- 2*-
 #.
,:%..7-
->b@,:0&=#- "#$+#2*- %&2*  
 ( :
!#+2*
""#$ 3)
+.#0. 1!.")2*+1*O*"#$
 $!.! !?5- >@
?- ,:
"*# ")*#)
$!5 :-*
?> "#$
 #.'()*
*!-;-! O5 :*@"#$-/0901'11*
<# -
 
  

. O/ 0 +5[ < 7- '+,*; 
58 * - ># "#$ 9 ./ .# -  %&  7 !* 
'1  2*
& 
!?7- . "271
-&+0..$* 0.") - 5 :7+/21;/
 - ,:.#/0*/0
2*-  ( 
*&+9+1

4. 4
"/0? !$
%

"#$+
!-
'12*
 
  
;:1!
58*4  
"#$.#0.5!+ .#
5 :&"=&% ,:.#5 :&"=&
58*"#$.#4
58*95."#$-7*+2*  7 !. O

4
!1!&O(%,: :
!#+"#$
-#$0'1!;- 7 !
!- 0&- "
- .9+1
0.")
58* 
"#$.#- 5 ? %.7 !%&21!4/!//!
*$!2*  
'! A

5. 4 !4
!;#
!;" A?  

:

-
 #.,:%.2*  
1!"-
 #.,:5 ?.. A*
'1!-7*+ ,:; 
>0&#
- . (-
 #.,:%.2*O*
&-  A
9+1 
- -
01*9./1!5f&
&.'1!-7*+/ \
-#$0-
- %&,:- 0
?.?>
:+
!?7- .."#$-7*+2* : 
<<& .B. 2510 ,:I

,-19'
&$.
&.) D($
!+1!-
7-
->b@0&=#- 5f&
&"#$+#"
- . (Good Pharmacy Practices) +
;+ :

- :
0*- "#$+
;*2*- 0
?. --
-
 #.
$!2719+1?> 
 #."#+$ #
D($.#')*!*"#$<
$!2719+1"#$.#0.5!+,:.#?> +*#)
- 0
?.')*!*-
 #.,:%.
- 0
?.- 5*
5kl!*
-  0;!
0. '!"#$%&
- ?/. 0;0&
 :7@
$! 0;!
?>
-  0;!
!$*"#$;
58*,:. O+
*&*- 9+12*  

- ># - "#$
 #  .271 " 7!+
 !+7 !"  7 
%41 56 0 
I : 
- :
0*-
 #. %. ;:1!!1!&.7-0&- "
- .,:;:1!+
*&*-
+10
"*&-
 #.,

5!+
)! (aseptic techniques)

")*#)   
"#$;:"-
 # .,:%..
  
  
 1! 
; + :

271 %41 "#$
-#$  0'1 ! -

-
 #  .,:%.5f&
 &  .7 -
->b@ -  5f&
 & " 

- ."#$+# !+;* .#- ;+"
*"(-- 0
?.-
 #.,:%. 0.").#- "
"0*
- :
0*- ?> !//!
*$!
$!5 :-*?> "#$%&

6.
"/06 = #
- ;+" -
 
  
 .?/5 :*@+ 0./!5 :
"B&,:
5 :*
58*7-
58*- ;+" - "#$
7.:.2*- 5h!-* - ,-19'5[<7 ,:
- -3?' '!09"2* :+
"#$;
58*'+9./9+1 + :7*-O(0.?1./,:-
5
5 :7+ ,/+"#$- !
-
&7
0>b@'! A ,:?+&"=&5 :*@'! :

5 :-*
?' / \ 9+121!1!& +*)*
$!271 -
 
  

58*"#$219+1%,:
58*
"#$
$!O! ;(9+1 /0.-*-7*+ P
->b@; &= .2*- ;+" -
 
  
Q
'()*
$!271!+1!-

"/06 = #? 6$
 +*#)
P>:"*;+"
 
  
Q "?-* ;-5f&
&7*1"#$+100.
&?"=&n
2; 5 /2 .7-0&- ,:.?/5 :*@/0* 0.
58*<2*A*:"#$
58*
?%41.#0. 41
,:5 :
- >@
58*!/+#2*- 5 :-!
0&# "#$9+1 :7*-O(&"=&%41560,:&"=&%41
&
,:;:O!5f&
&.
->b@/!95*#)
-. 2* ::
0"#$5f&
&7*1"#$ %41"*o 2*>:"*;:
58*%419./.#/0*
9+1/0*
#+ 2*=? -&;*
'1,:!?7- .%& +%41"*o 0.")4/. 
;:1 ! 9./
58 *
;1  '! 7?1 * / 0 * %41
& 7  4 - ;1  7 !"#$ 5 ( - 32*=? -& ; * 
'1  7 !
!?7- .%&,%*5[;;?
* 7 !;-.?*9 7 
.*?3@
'. 7-%41"* o
58*%41"#$
7 !-.#- - :""#$!;.#/0*9+1/0*
#
7 !"#$!;"271
-&+!&2*- &; >9+1 ;:,+*9./ /0.2*- &; >+&*+
!-
- 
I :- >#2*/0
0"#$>:"* o &; >*)* \
>:"*;+"
 
  
"?-* ;-*.,+0.
&?"=&n2;2*
- ;+" -
 
  
.
->b@; &= .+-/0

6
7
8
74

 2 
 
 
 .. 2549
2.1 
 
 

CREAMS

Betamethasone Dipropionate Cream (0.05%w/w of betamethasone)

Betamethasone Dipropionate 0.0643 g
(equivalent to Betamethasone 0.05 g)
Non-ionic Buffered Cream Base q.s. 100.00 g
Group : 13.4 Topical Corticosteroids
Betamethasone Valerate Cream (0.1%w/w of betamethasone)
Betamethasone Valerate (equivalent to Betamethasone 0.1 g) 0.1214 g
Non-ionic Buffered Cream Base q.s. 100.00 g
Group : 13.4 Topical Corticosteroids
Hydrocortisone Acetate Cream (1%w/w of Hydrocortisone acetate)
Hydrocortisone Acetate 1.00 g
Non-ionic Buffered Cream Base q.s. 100.00 g
Group : 13.4 Topical Corticosteroids
Methyl Salicylate Cream Compound
Methyl Salicylate 15.00 ml
Menthol 6.00 g
Eugenol 2.00 ml
Cajuput Oil 1.20 ml
Turpentine Oil 1.50 ml
Cetyl Alcohol 1.75 g
Stearyl Alcohol 1.75 g
Glyceryl Stearate and PEG-100 Stearate mixture (Aracel 165) 2.00 g

1
 White Beeswax (White Wax) 2.00 g
Liquid Paraffin 2.00 ml
Carbomer 940 0.80 g
Propylene Glycol 5.00 ml
Sodium Lauril Sulfate (Sodium Lauryl Sulfate) 1.00 g
Triethanolamine q.s.
Preservatives q.s.
Purified Water q.s. 100.00 g
Group : 10.3 Drugs for the relief of soft-tissue inflammation
Prednisolone Cream
Prednisolone 0.50 g
Non-ionic Buffered Cream Base q.s. 100.00 g
Group : 13.4 Topical Corticosteroids
Sulfadiazine Silver (Silver Sulfadiazine) Cream
Sulfadiazine Silver 1.00 g
Carbomer 940 0.30 g
Triethanolamine 0.30 ml
Propylene Glycol 2.50 ml
Cetyl Alcohol 7.00 g
Liquid Paraffin 23.50 ml
Polysorbate 80 6.50 ml
Wool Fat 1.00 g
Paraben Conc 1.00 ml
Purified Water q.s. 100.00 g
Group : 13.1.1 Antibacterial Preparations

2
Triamcinolone Acetonide Cream
Triamcinolone Acetonide 0.02 ;<=> 0.10 g
Non-ionic Buffered Cream Base q.s. 100.00 g
Group : 13.4 Topical Corticosteroids
Urea Cream
Urea 5.00-40.00 g
Non-ionic Buffered Cream Base q.s. 100.00 g
Group : 13.2 Emollient and Barrier Preparations

EAR DROPS

Sodium Bicarbonate Ear Drop

Sodium Bicarbonate 5.00 g
Glycerol (Glycerin) 30.00 ml
Purified Water q.s. 100.00 ml
Group : 12.1 Drugs Acting on the Ear
Note : @ABCDEF=G>EHIJKCG>LM;NOFP 15-25 >QRAESTESC@UVWFC>A@LXFYEHPB 4 UZ[\A;]
;TZQE^<C@F@A
ELIXIRS

Potassium Chloride Elixir

Potassium Chloride 10.00 g
Ethyl Alcohol 95% 3.20 ml
Aspartame 0.03 g
Cream Soda 0.03 ml
Edicol Apple Green 1% 0.3 ml
Simple Syrup 50.00 ml
Paraben Conc 1.00 ml

3
 Purified Water q.s. 100.00 ml
Group : 9.2 Fluids and Electrolytes
Note : 15 ml [<WH>J\`a@ Potassium 20 mEq

LOTIONS

Benzyl Benzoate Lotion

Benzyl Benzoate 25.00 g
Emulsifying Wax B.P. 2.00 g
Purified Water q.s. 100.00 ml
Group : 13.1.3 Parasiticidal Preparations
Calamine Lotion
Calamine, in fine powder 15.00 g
Zinc Oxide, in fine powder 5.00 g
Bentonite 3.00 g
Sodium Citrate 0.50 g
Glycerol (Glycerin) 5.00 ml
Flavouring Agent q.s.
Purified Water q.s. 100.00 ml
dB^eA<ZJ>AVEfPGF
Liquified Phenol 0.50 g
Camphor 0.10 g
Menthol 0.10 g
Group : 13.3 Topical Antipruritics
Salicylic Acid Lotion
Salicylic Acid 3.00 g
Ethyl Alcohol 95% 25.00 ml
Purified Water 25.00 ml
4
 Propylene Glycol q.s. 100.00 ml
Group : Other Preparations for Psoriasis (excluding Topical Corticosteroids)
Note : >AVE^PF Lactic acid, Urea >@YAQTW 1 % gTW@ABCDVWFC>A@LXFYEHPB 4 UZ[\A;]
;TZQE^<C@F@A
Triamcinolone Acetonide Lotion
Triamcinolone Acetonide 0.10 g
Lactic Acid 10.00 ml
Acetone 1.00 ml
Ethyl Alcohol 95% 5.00 ml
Propylene Glycol 50.00 ml
Paraben Conc 1.00 ml
Purified Water q.s. 100.00 ml
Group : 13.4 Topical Corticosteroids
Zinc Sulfate Lotion
Synonyms : White Lotion
Zinc Sulfate 4.00 g
Sulfurated Potash 4.00 g
Purified Water q.s. 100.00 ml
Group : 13.2 Emollient and Barrier Preparations
Note : - Eh@YAha\HY>Bdi`
- @ABCDEF=G>EHIJKCG>LM;NOFP 15-25 >QRAESTESC@UVWFC>A@LXFYEHPB 4 UZ[\A;]
;TZQE^<C@F@A

MIXTURES

Ammonium Carbonate and Senega Mixture

Ammonium Carbonate 0.80 g
Ipecacuanha Tincture 2.00 ml
5
 Senega Tincture 6.66 ml
Methyl Hydroxybenzoate (Methylparaben) 0.10 g
Propyl Hydroxybenzoate (Propylparaben) 0.02 g
Purified Water q.s. 100.00 ml
Group : 3.6.2 Expectorant and Demulcent Cough Preparations
Note : HY>BVYA@@Ad;`EV=>VAQ\`a@BDAe Ei=G>FdB>Z^<AUYaB 1 : 1
Compound Cardamom Mixture
Synonyms : Compound Cardamom Mixture; Mist Carminative
Compound Cardamom Tincture 1.20 ml
Capsicum Tincture (Capsic Tincture) 0.40 ml
Ginger Tincture 0.80 ml
Camphor 0.20 ml
Ethyl Alcohol 95% 13.45 ml
Purified Water q.s. 100.00 ml
Group : 1.1 Antacids and Other Drugs for Dyspepsia
Magnesium Sulfate Mixture
Synonyms : Mist. Alba; White Mixture
Magnesium Sulfate 40.00 g
Light Magnesium Carbonate 5.00 g
Peppermint Spirit 2.50 ml
Purified Water q.s. 100.00 ml
Group : 1.6 Laxatives
Note : - <WFZ\<WaZQHA<di`dBlO`[ma@n<oX^gTW^ZJ
- @ABCDEF=G>EHIJKCG>LM;NOFP 15-25 >QRAESTESC@UVWFC>A@LXFYEHPB 4 UZ[\A;]
;TZQE^<C@F@A

6
Opium and Glycyrrhiza Mixture Compound
Synonyms : Brown Mixture; Mist. Tussis
Glycyrrhiza Fluidextract 12.00 ml
Antimony Potassium Tartrate 24.00 mg
Camphorated Opium Tincture 12.00 ml
Glycerol (Glycerin) 12.00 ml
Purified Water q.s. 100.00 ml
Group : 3.6.1 Cough Suppressants
Squill and Ammonia Mixture
Ammonium Carbonate 2.00 g
Squill Tincture 3.40 ml
Camphorated Opium Tincture 13.33 ml
Senega Tincture 12.00 ml
Syrup 6.70 ml
Purified Water q.s. 100.00 ml
Group : 3.6.1 Cough Suppressants

NASAL DROPS

Ephedrine Hydrochloride Nasal Drop

Ephedrine Hydrochloride 0.50-3.00 g
Purified Water q.s. 100.00 ml
Group : 12.2.2 Topical Nasal Decongestants
Note : @ABCDEF=G>EHIJKCG>LM;NOFP 15-25 >QRAESTESC@UVWFC>A@LXFYEHPB 4 UZ[\A;]
;TZQE^<C@F@A

7
 OINTMENTS

Benzoic Acid and Salicylic Acid Ointment

Synonyms : Whitfieldps Ointment
Benzoic Acid, fine powder 6.00 g
Salicylic Acid, fine powder 3.00 g
Hydrophilic Ointment Base q.s. 100.00 g
Group : 13.1.2 Antifungal Preparations
Coal Tar Ointment
Coal Tar 3.00-5.00 g
Polysorbate 80 0.50 g
Hydrophilic Ointment Base q.s. 100.00 g
Group : Other Preparations for Psoriasis (Excluding Topical Corticosteroids)
Dithranol (Anthralin) Ointment
Dithranol 0.10-1.00 g
Lassarp s Paste q.s. 100.00 g
LassarP s Paste
Zinc Oxide 24.00 g
Corn Starch 24.00 g
Salicylic Acid 1.00 g
White Soft Paraffin 50.00 g
Group : Other Preparations for Psoriasis (Excluding Topical Corticosteroids)
Methyl Salicylate Ointment Compound
Synonyms : Analgesic Balm
Methyl Salicylate 25.00 ml
Hard Paraffin 15.20 g
White Beeswax (White Wax) 7.00 g

8
 White Vaseline 33.00 g
Menthol 10.00 g
Camphor 5.00 g
Peppermint Oil 0.45 g
Eucalyptus Oil 2.75 g
Clove Oil 0.10 g
Capsicum Tincture (Capsic Tincture) 1.50 g
Group : 10.3 Drugs for the relief of soft-tissue inflammation
Nitrofural (Nitrofurazone) Ointment
Synonyms : Nitrofurazone Soluble Dressing
Nitrofurazone 0.20 g
Polyethylene Glycol 400 66.60 ml
Polyethylene Glycol 4000 33.30 g
Group : 5.6 Antiseptics
Salicylic Acid Ointment
Salicylic Acid 3.00-5.00 g
Hydrophilic Ointment Base q.s. 100.00 g
Group : 13.6 Preparations for Warts and Calluses
Sulfur (Sulphur) Ointment
Precipitated Sulfur 6.00-10.00 g
Luquid paraffin (Mineral Oil) 10.00 ml
White Ointment q.s. 100.00 g
White Ointment
White Beeswax (White Wax) 5.00 g
White Soft Paraffin 95.00 g
Group : 13.1.3 Parasiticidal Preparations

9
Urea Ointment
Urea 20.00-40.00 g
Hydrophilic Ointment Base q.s. 100.00 g
Group : 13.2 Emollient and Barrier Preparations

PAINTS
Iodine Paint, Compound
Synonyms : Mandl's Paint
lodine 1.25 g
Potassium lodide 2.50 g
Purified Water 2.50 ml
Peppermint Oil 0.40 ml
Glycerol (Glycerin) q.s. 100.00 ml
Group : 12.3.1 Oropharyngeal Antiseptics
Podophyllin Paint (Podophyllum Resin)
Synonyms : Podophyllin Paint, Compound
Podophyllum Resin 10.00-25.00 g
Compound Benzoin Tincture q.s. 100.00 ml
Group : 13.6 Preparations for Warts and Calluses
PASTES
Salicylic Acid Paste
Salicylic Acid 3.40 g
Glycerol (Glycerin) 5.00 g
Zinc Oxide, fine powder 25.00 g
Starch 25.00 g
White Soft Paraffin q.s. 100.00 g
Group : 13.6 Preparations for Warts and Calluses

10
Zinc Oxide Paste
Zinc Oxide, fine powder 25.00 g
Starch, fine powder 25.00 g
White Soft Paraffin q.s. 100.00 g
Group : 13.2 Emollient and Barrier Preparations
POWDERS

Macrogol Oral Powder

Synonyms : Polyethylene Glycol; PEG Lavage
Polyethylene Glycol 4000 5.50 g
Potassium Chloride 0.07 g
Sodium Chloride 0.15 g
Sodium Bicarbonate 0.17 g
Sodium Sulfate 0.57 g
Group : 1.6 Laxatives
Note : lUFBDeA 100 ml
Oral Rehydration Salts
Synonyms : O.R.S.
Sodium Chloride 2.60 g
Trisodium Citrate Dihydrate 2.90 g
Potassium Chloride 1.50 g
Glucose 13.50 g
Group : 1.4 Drugs Used in Acute Diarrhoea
Note : E[sBUO^<E^<C@FlQEHT=>g<YUeA;<ZJlUFBDeA 1 TP^< EF=G>lUFBDeA 1 TP^<gT`aVWFC
Glucose 75 mEq, Sodium 75 mEq (mmol), Chloride 65 mEq (mmol),
Potassium 20 mEq (mmol), Citrate 10 mEq (mmol), Osmolarity 245
mOsm

11
 SCRUBS

Povidone-Iodine Scrub
Povidone-iodine 7.50 g
Sodium Lauril Sulfate (Sodium Lauryl Sulfate) (LZV) 20.00 g
Cocamide DEA 3.00 ml
Isopropyl Myristate 0.75 ml
Propylene Glycol 1.50 ml
Sodium Chloride 0.25 g
Preservative q.s.
Citric Acid q.s. to pH 4.5-5.0
EDTA 0.075 g
Purified Water q.s. 100.00 ml
Group : 5.6 Antiseptics

SHAMPOOS

Tar Shampoo
Coal Tar Solution 5.00 ml
Shampoo Base q.s. 100.00 ml
Shampoo Base
Sodium Lauryl Ether Sulfate 20.00 gm
Sodium Lauril Sulfate (Sodium Lauryl Sulfate) Needle 20.00 gm
EDTA 0.10 gm
Polysorbate 80 1.00 ml
Cocamidopropyl Betaine 4.00 ml
Cocamide diethanolamide (Cocamide DEA) 4.00 ml
Polyethylene Glycol 400 4.00 ml

12
 Propylene Glycol 3.00 ml
Glycerol (Glycerin) 3.00 ml
Panthenol (D-panthenol) 0.20 ml
Sodium Chloride 2.00 gm
Methyl Hydroxybenzoate (Methylparaben) 0.10 gm
Propyl Hydroxybenzoate (Propylparaben) 0.02 gm
Citric Acid q.s. to pH 4.5-5.5
Deionized Water q.s. 100.00 ml
Group : 13.5 Other Preparations for Psoriasis (Excluding Topical
Corticosteroids)
Note : >AVE^PF Salicylic Acid 3.0% X\`

SOLUTIONS

Aluminium Acetate Solution

Synonyms : Burow's Solution
Aluminium Subacetate Solution 54.50 ml
Glacial Acetic Acid 1.50 ml
Purified Water q.s. 100.00 ml
Aluminium Subacetate Solution
Aluminium Sulfate 14.50 g
Acetic Acid 16.00 ml
Precipitated Calcium Carbonate 7.00 g
Purified Water q.s. 100.00 ml
dB^eA<ZJ>AVFC Boric Acid 0.90 g
Group : 13.2 Emollient and Barrier Preparations
Note : HY>Bdi`d;`EV=>VAQ\`a@BDAe 1:10 - 1:40

13
Cloral Hydrate Oral Solution
Synonyms : Chloral Hydrate Oral Solution; Chloral Hydrate Mixture, Pediatric
Cloral Hydrate (Chloral hydrate) 10.00 g
Citric Acid, Monohydrate 0.75 g
Paraben Conc 1.00 ml
Glycerol (Glycerin) 10.00 ml
Purified Water 20.00 ml
Color, Flavor q.s.
Simple Syrup q.s. 100.00 ml
Group : 4.1 Hypnotics and Anxiolytics
Storage : oa<di`NA@dB 3 E\=>B EF=G>EHIJ@AKCG>LM;NOFP;`>Q
Note : h`>;`AFdi` 1. Hypersentivity 2. Severe hepatic impairment 3. Severe
renal impairment 4. gastritis
Copper Sulfate Sterile Solution
Copper (II) sulfate (CuSO4.5H2O) 0.157 g
Distilled Water q.s. 100.00 ml
Group : 9.5 Minerals
Ethyl Alcohol Solution
Synonyms : Ethyl Alcohol 70%
Ethyl Alcohol 95% 73.70 ml
Purified Water q.s. 100.00 ml
Group : 5.6 Antiseptics
Note : oa<g^YQUC\`a@ Brilliant Blue

14
Glycerol Oral Solution
Glycerol (Glycerin) 50.00 ml
Peppermint Spirit, Color q.s.
Purified Water q.s. 100.00 ml
Group : 11.4 Drugs for Treatment of Glaucoma
Intraperitoneal Dialysis Solution (Isotonic Solution) (1.5% Dextrose in Dialysis)
Dextrose, anhydrous 15.00 g
Sodium Chloride 5.56 g
Sodium Acetate 4.49 g
Calcium Chloride 0.257 g
Magnesium Chloride 0.05-0.10 g
Sodium Metabisulfite 0.01 g
Water for Injection q.s. 1000.00 ml
Group : 9.2 Fluids and Electrolytes
Intraperitoneal Dialysis Solution (2.5% Dextrose in Dialysis)
Anhydrous Dextrose 25.00 g
Sodium Chloride 5.56 g
Sodium Lactate 4.49 g
Calcium Chloride 0.257 g
Magnesium Chloride 0.05-0.10 g
Sodium Metabisulfite 0.01 g
Water for Injection q.s. 1000.00 ml
Group : 9.2 Fluids and Electrolytes
Intraperitoneal Dialysis Solution (4.25% Dextrose in Dialysis)
Anhydrous Dextrose 42.50 g
Sodium Chloride 5.56 g
Sodium Lactate 4.49 g
15
 Calcium Chloride 0.257 g
Magnesium Chloride 0.05-0.10 g
Sodium Metabisulfite 0.01 g
Water for Injection q.s. 1000.00 ml
Group : 9.2 Fluids and Electrolytes
Lugol's Solution
Synonyms : Aqueous Iodine Oral Solution, Strong Iodine Solution
Iodine 5.00 g
Potassium lodide 10.00 g
Purified Water q.s. 100.00 ml
Group : 6.2.2 Antithyroid Drugs
Magnesium Sulfate Solution
Synonyms : Saturated Magnesium Sulfate Solution
Magnesium Sulfate 50.00 g
Purified Water q.s. 100.00 ml
Group : 1.6 Laxatives
Note : @ABCDEF=G>EHIJKCG>LM;NOFP 15-25 >QRAESTESC@UVWFC>A@LXFYEHPB 4 UZ[\A;]
;TZQE^<C@F@A
Neutral Phosphate Oral Solution
Dibasic Sodium Phosphate (Disodium Hydrogen Phosphate) 0.539 g
Potassium Dihydrogen Phosphate 1.30 g
Monobasic Sodium Phosphate Dihydrate 0.297 g
(Sodium Dihydrogen Phosphate Dihydrate)
Glycerol (Glycerin) 5.00 ml
Simple Syrup 40.00 ml
Paraben Conc 1.00 ml
Purified Water q.s. 100.00 ml
16
Group : 9.5 Minerals
Note : 5 ml [<WH>J\`a@ Sodium, Potassium >@YAQTW 0.475 mEq gTW
Phosphate 0.95 mEq
Potassium Acetate Sterile Solution
Potassium Acetate 2.95 g
Water for Injection q.s 10.00 ml
Group : 9.2 Fluids and Electrolytes
Note : - 5 ml [<WH>J\`a@ Potassium 15 mEq
- oa<di`>@YAQ<WFZ\<WaZQdBlO`[ma@n<o;ZadV
- XFYoa<di`dBlO`[ma@KCGHA<KeAQABh>QX^JHf<Y>QgTWFC>AHA<[tUUAaWB`>@ XFYFC
[tUUAaW NAaWET=>\oZGQXBn^<EVB (Azotemia) Addisonps Disease NAaWKCGFC
n[g^UESC@FdBET=>\UOQ
- XFYoa<di`@AdBlO`[am @KCGX\`<ZJ Potassium-sparing Diuretics
- @AuC\Eh`A;T>\ET=>\\eAoa<d;`>@YAQi`A v Ef<AWw`AoaAFEh`Fh`Bh>Qn[g^UESC@F
dBET=>\UOQ VWFClT^Y>HA<KeAQABh>Q;ZadV NAaW Peripheral gTW Pulmonary
Edema
Potassium Citrate Oral Solution
Potassium Citrate 6.60 g
Orange Powder 0.005 g
Paraben Conc 1.00 ml
Purified Water q.s. 100.00 ml
Group : 7.4.3 Drugs Used in Alkalinisation of Urine gTW 9.2 Fluids and
Electrolytes
Povidone-lodine Solution
Povidone-lodine 10.00 g
Propylene Glycol 0.25 ml

17
 Polyethylene Glycol 400 0.50 ml
Dibasic Sodium Phosphate 1.32 g
(Sodium Phosphate, Disodium Phosphate)
Citric Acid 0.92 g
Cetomacrogol 1000 ;<=> Nonoxinol 9 0.02 g
Purified Water q.s. 100.00 ml
Group : 5.6 Antiseptics
Note : @AFC pH = 4-5
Saturated Solution of Potassium Iodide Oral Solution (SSKI)
Potassium Iodide 100.00 g
Sodium Thiosulfate 0.05 g
Purified Water q.s. 100.00 ml
Group : 6.2.2 Antithyroid Drugs
Sodium Acetate Sterile Solution
Sodium Acetate 4.07 g
Water for Injection q.s 10.00 ml
Group : 9.2 Fluids and Electrolytes
Note : - 5 ml [<WH>J\`a@ Sodium 20 mEq
- di`>@YAQ<WFZ\<WaZQdBlO`[ma@n<o;ZadVT`FE;Ta oaAF\ZBnT;P^UOQ HA<KeAQAB
h>QX^JHf<Y>Q NAaW Peripheral gTW Pulmonary Edema
Sodium Citrate and Citric Acid Oral Solution
Synonyms : Shohlps solution
Methyl Hydroxybenzoate (Methylparaben) 0.035 g
Propyl Hydroxybenzoate (Propylparaben) 0.025 g
Ethyl Alcohol 95% 1.50 ml
Sucrose 5.00 g
Sodium Citrate dihydrate 10.00 g

18
 Citric Acid anhydrous 6.00 g
Lemon Oil q.s.
Color q.s.
Purified Water q.s. 100.00 ml
Group : 7.4.3 Drugs Used in Alkalinisation of Urine
Note : 5 ml [<WH>J\`a@ Sodium 5 mEq SCGQd;` bicarbonate [<WFAM 5 mEq
Sodium Citrate and Potassium Citrate Oral Solution
Sodium Citrate 24.80 g
Potassium Citrate 27.20 g
Propylene Glycol 10.00 ml
Simple Syrup 20.00 ml
Purified Water q.s. 100.00 ml
Group : 7.4.3 Drugs Used in Alkalinisation of Urine
Note : 5 ml [<WH>J\`a@ Sodium, Potassium >@YAQTW 12.65 mEq
Sodium Thiosulfate Solution
Sodium Thiosulfate 20.00 g
Purified Water q.s. 100.00 ml
Group : 13.1.2 Antifungal Preparations
Note : @ABCDEF=G>EHIJKCG>LM;NOFP 15-25 >QRAESTESC@U VWFC>A@LXFYEHPB 4 UZ[\A;]
;TZQE^<C@F@A
Tincture of Iodine Solution (lodine in Alcohol)
Synonyms : Weak lodine Solution; lodine Tincture
Iodine 2.50 g
Potassium Iodine 2.50 g
Purified Water 2.50 ml
Ethyl Alcohol 95% q.s. 100.00 ml
Group : 5.6 Antiseptics
19
Trace Element Solution (Oral Solution)
Zinc Sulfate (ZnSO4.7H2O) 5.719 g
Manganese sulfate (MnSO4.H2O) 0.923 g
Copper (II) sulfate pentahydrate (CuSO4.5H2O) 0.707 g
Potassium Iodide (KI) 0.026 g
Chromic Trichloride (CrCl3.6H2O) 0.012 g
Sodium Molybdate (Na2MoO4.2H2O) 0.008 g
Cobalt (II) Sulfate Heptahydrate (CoSO4.7H2O) 0.008 g
Distilled Water q.s. 1000.00 ml
Group : 9.5 Minerals
Note : Distilled Water KCGdi`E^<C@F@AHTLYF Minerals ^`>Q[<ARVAH Minerals
Zinc Sulfate Sterile Solution
Zinc Sulfate (ZnSo4.7H2o) 0.44 g
Distilled Water q.s. 100.00 ml
Group : 9.5 Minerals

SPIRITS

Aromatic Ammonia Spirit

Ammonium Carbonate 3.20 g
Ammonia Solution 30% 3.50 ml
Lemon Oil 1.00 ml
Lavender Oil 0.10 ml
Ethyl Alcohol 95% 70.00 ml
Purified Water q.s. 100.00 ml
Group : 3.8 Other respiratory preparations

20
 SUSPENSIONS

Aluminium Hydroxide and Magnesium Hydroxide Suspension

Synonyms : Alumina and Magnesia Oral Suspension
Aluminium Hydroxide Compressed Gel equivalent to
Aluminium Oxide 3.56 g
Magnesium Hydroxide Paste equivalent to Magnesium
Hydroxide 1.80 g
Sorbitol Solution 70% 10.00 ml
Syrup U.S.P. 5.00 ml
Paraben Conc 1.00 ml
Peppermint Oil q.s.
Color q.s.
Purified Water q.s. 100.00 ml
Group : 1.1 Antacids and Other Drugs for Dyspepsia
Note : d;`FCUYaB[<WH>J Al2O3 = 3.1-4.0 % w/w , Mg(OH)2 = 1.4-2.2 % w/w
Aluminium Hydroxide Suspension
Synonyms : Aluminium Hydroxide Gel; Colloidal Aluminium Hydroxide; Aluminium
Hydroxide Mixture
Aluminium Hydroxide Paste equivalent to Aluminium Oxide 4.00 g
Glycerol (Glycerin) 9.33 ml
Sorbitol Solution 5.00 ml
Peppermint Oil 0.026 ml
Methyl Hydroxybenzoate (Methylparaben) 0.10 g
Propyl Hydroxybenzoate (Propylparaben) 0.02 g
Purified Water q.s. 100.00 ml
Group : 1.1 Antacids and other drugs for dyspepsia gTW 9.5 Minerals
Note : [<ZJoaAF;B=\\`a@ Suspending Agent ^AFoaAFE;FAWUF
21
Bentonite Magma Suspension
Synonyms : Bentonite Magma
Bentonite 7.00 g
Glycerol (Glycerin) 20.00 ml
Paraben Conc 1.00 ml
Purified Water q.s. 100.00 ml
Group : 16. Antidotes
Note : @ABCDEF=G>EHIJKCG>LM;NOFP 15-25 >QRAESUESC@U VWFC>A@LXFYEHPB 4 UZ[\A;]
;TZQE^<C@F@A
Magnesium Hydroxide Suspension
Synonyms : Milk of Magnesia
Magnesium Hydroxide 7.50 g
Glycerol (Glycerin) 9.33 ml
Sorbitol Solution 5.00 ml
Peppermint oil 0.026 ml
Methyl Hydroxybenzoate (Methylparaben) 0.10 g
Propyl Hydroxybenzoate (Propylparaben) 0.02 g
Citric Acid 0.10 g
Purified Water q.s. 100.00 ml
Group : 1.1 Antacids and Other Drugs for Dyspepsia, 1.6 Laxatives gTW 9.5
Minerals
Note : [<ZJoaAF;B=\\`a@ Suspending Agent ^AFoaAFE;FAWUF
Mebendazole Suspension
Mebendazole 2.00 g
Carboxymethyl Cellulose Sodium (medium viscosity grade) 1.00 g
Citric Acid 0.30 g
Sorbitol Solution 10.00 ml
22
 Syrup 12.00 ml
Paraben Conc 1.00 ml
Flavouring Agent q.s.
Purified Water q.s. 100.00 ml
Group : 5.5 Anthelmintics
Note : g^YQUCgTWHTPGBX\`^AFKCGE;IBE;FAWUF

SYRUPS

Acetaminophen (Paracetamol) Syrup

Synonyms : Acetaminophen (Paracetamol) Syrup, Pediatric
Acetaminophen (Paracetamol) 24.00 g
Polyethylene Glycol 1500 75.00 g
Glycerol (Glycerin) 150.00 ml
EDTA 0.10 g
Methyl Hydroxybenzoate (Methylparaben) 1.00 g
Propyl Hydroxybenzoate (Propylparaben) 0.20 g
Syrup 400.00 ml
Sorbitol Solution 70% 100.00 ml
Citric Acid 0.30 g
Sodium Citrate 1.00 g
Sodium Chloride 0.20 g
Color, Flavor q.s.
Purified Water q.s. 1,000.00 ml
Group : 4.6 Analgesics and Antipyretics

23
Chlorpheniramine Maleate Syrup
Synonyms : Chlorpheniramine Syrup, Pediatric
Chlorpheniramine Maleate 0.04 g
Simple Syrup 40.00 ml
Sorbitol Solution 10.00 ml
Paraben Conc 1.00 ml
Color, Flavor q.s.
Purified Water q.s. 100.00 ml
pH = 4 - 5
Group : 3.4 Antihistamines
Note : EfPGFoaAF;B=\ g^YQUCgTWHTPGBX\`^AFoaAFE;FAWUF
Ferrous Sulfate Drops
Ferrous Sulfate 12.50 g
Citric Acid 0.20 g
Paraben Conc 1.00 ml
Syrup q.s. 100.00 ml
Group : 9.5 Minerals
Storage : EHIJd;`f`BgUQ d;`J<<VLdBha\UCiA
Note : 100 ml [<WH>J\`a@ ferrous ion 2.5 g
Glyceryl Guaiacolate Syrup
Guaifenesin (Glyceryl Guaiacolate) 2.00 g
Citric Acid 0.80 g
Sodium Citrate 0.05 g
Sodium Chloride 0.50 g
Menthol 0.03 g
Paraben Conc 1.00 ml

24
 Glycerol (Glycerin) 10.00 ml
Polyethylene Glycol 4000 10.00 g
Syrup 50.00 ml
Ethyl Alcohol 95% 0.03 ml
Color, Flavor q.s.
Purified Water q.s. 100.00 ml
Group : 3.6.2 Expectorant and Demulcent Cough Preparations
Potassium Chloride Syrup
Potassium Chloride 10.00 g
Citric Acid 0.60 g
Aspartame 0.10 g
Menthol 0.01 g
Methyl Hydroxybenzoate (Methylparaben) 0.10 g
Propyl Hydroxybenzoate (Propylparaben) 0.02 g
Sorbitol Solution 20.00 ml
Purified Water 30.00 ml
Flavoring Agent q.s.
Syrup q.s. 100.00 ml
Group : 9.2 Fluids and Electrolytes
Note : 15 ml [<WH>J\`a@ Potassium 20 mEq
TINCTURES
Thiomersal (Thimerosal) Tincture
Thiomersal (Thimerosal) 0.10 g
Ethyl Alcohol 95% 52.50 ml
Acetone 10.00 ml
Ethylenediamine 0.02 g
Monoethanolamine 0.10 g
25
 Merbromin (Mercurochrome) 0.40 g
Purified Water q.s. 100.00 ml
Group : 5.6 Antiseptics
DENTAL PREPARATIONS

Artificial Saliva Solution (Saliva Substitutes)

Carboxymethyl Cellulose Sodium 0.30 g
Magnesium Sulfate 0.003 g
Potassium Chloride 0.06 g
Monobasic Sodium Phosphate Dihydrate 0.05 g
(Sodium Dihydrogen Phosphate Dihydrate)
Glycerol (Glycerin) 2.00 ml
Paraben Conc 1.00 ml
Purified Water q.s. 100.00 ml
Group : 12.3.3 Other Dental Preparations
Storage : EHIJdBNAiBW[|\UBPK dB^OE` @IB
Camphorated Parachlorophenol Solution
Synonyms : Chlorocamphene
Camphor 21.00 g
Parachlorophenol (4-Chlorophenol ) 9.00 g
Group : 12.3.1 Oropharyngeal Antiseptics
Storage : EHIJdBNAiBW[|\UBPK [}>QHZBgUQg\\
Note : - <WoA@Eo=>QlPa;BZQgTWEB=D>E@=G>
- E^<C@F@A^ZaBCdD B Hood ^T>\hZDB^>B gTWUaFwLQF=>

26
Camphorated Phenol Solution
Synonyms : Camphophenol
Phenol 30.00 g
Camphor 60.00 g
Liquid Paraffin q.s. 100.00 ml
Group : 12.3.1 Oropharyngeal Antiseptics
Storage : EHIJdBNAiBW[|\UBPK [}>QHZBgUQg\\
Note : - <WoA@Eo=>QlPa;BZQgTWEB=D>E@=G>
- E^<C@F@A^ZaBCdD B Hood ^T>\hZDB^>B gTWUaFwLQF=>
CarnoyPs Solution
Absolute Ethyl Alcohol 6.00 ml
Chloroform 3.00 ml
Glacial Acetic Acid 1.00 ml
Ferric Chloride 1.00 g
Group : 12.3.3 Other Dental Preparations
Storage : EHIJdBha\gH`aUCiA [}>QHZBgUQg\\
Note : - UYaB[<WH>JE[sBUA<FCfP~ ^`>Q<WFZ\<WaZQdBHA<di`
- UA<<WE;@h>Q Absolute Ethyl Alcohol E[sBUA<XaX
EDTA Solution
EDTA 14.30 g
Cetrimide 0.083 g
Sodium Hydroxide 1.00 g
Distilled Water q.s. 100.00 ml
Group : 12.3.3 Other Dental Preparations
Storage : EHIJdBNAiBWKCGXFYE[sBnT;W;BZH
Note : - XFYd;`di`KCGlPatB (tooth surface) Ef<AW>AVKeAd;`tBUOEUC@goTESC@F (Tooth
Decalcification)
27
 - d;`E^<C@Fdi`hMWBZDBET@ (Freshly Prepared)
- ^eA<ZJBCD^`>Q<WaZQEHCG@aHZJBDeAKCdG i` Ef<AW EDTA E[sB Chelating Agent BDeA
^`>QJ<PULKPFAH v
Fluocinolone Acetonide Gel
Fluocinolone Acetonide 0.18 g
Ethyl Alcohol 95% 1.82 ml
Propylene Glycol 45.45 ml
Polyethylene Glycol 400 36.36 ml
Paraben Conc 1.82 ml
Carboxymethylcellulose 1500 4.36 g
Glycerol (Glycerin) 14.55 ml
Hot Water 100.00 ml
Group : 12.3.3 Other Dental Preparations
Fluocinolone Acetonide Solution
Fluocinolone Acetonide 0.18 g
Ethyl Alcohol 95% 1.82 ml
Propylene Glycol 45.45 ml
Polyethylene Glycol 400 36.36 ml
Paraben Conc 1.82 ml
Carboxymethylcellulose 1500 0.91 g
Glycerol (Glycerin) 3.64 ml
Hot Water 100.00 ml
Group : 12.3.3 Other Dental Preparations

28
Formaldehyde and Cresol Solution
Synonyms : Cresolated Formaldehyde; Formocresol
Formocresol Conc
Formaldehyde (Formalin) 37-38 % 19.00 ml
Cresol 35.00 ml
Glycerol (Glycerin) 25.00 ml
Steriled Water 21.00 ml
d;`EHIJ Formocresol Conc dBha\gH`aUCiA HY>BBeAFAdi`d;`EV=>VAQHY>B\`a@
Glycerol gTW Water dB>Z^<AUYaB Glycerol : Water : Formocresol Conc =
3:1:1 (240 ml : 80 ml : 80 ml)
Group : 12.3.1 Oropharyngeal Antiseptics
Storage : EHIJdBNAiBW[|\UBPK [}>QHZBgUQg\\
Note : - E^<C@F@AdB Hood EB=G>QVAHFCUYaB[<WH>Jh>Q Formaldehyde
- >ZB^<A@h>Q Formaldehyde X><WE;@VWKeAd;`<WoA@Eo=>Q^A VFOH <WJJ
KAQE\PB;A@dVgTW>AVKeAd;`EHP\HA<X> HT=BTeAJAH (Dysphagia) KAQE\PB
;A@dVEHP\HA<;\EH<IQgTWJaF [>\JaF ;>J ;AHUA<TWTA@KCGEh`Fh`BUOQ v
wOHlPa;BZQKeAd;`lPa;BZQhAagTWghIQ\`AB KeAd;`EHP\l=GBgf`UZFlZUgTW>AHA<gf`
- Glycerol iYa@[}>QHZBHA<EHP\^WH>BKCGEHP\VAH Polymerization h>Q
Formaldehyde E[sB Solid Paraformaldehyde
TalbotPs Solution
Synonyms : Iodine and Zinc Iodide Glycerite
Zinc Iodide 4.00 g
Iodine, Crystal 3.00 g
Glycerol (Glycerin) 60.00 ml
Purified Water 40.00 ml
Group : 12.3.1 Oropharyngeal Antiseptics
Storage : EHIJdBNAiBWKCG[\| UBPK [}>QHZBgUQgTWoa<EHIJdBKCEG @IBEf<AW Iodine E[sBUA<<WE;P\

29
WhiteheadPs Varnish
Synonyms : Compound Paint of Iodoform BPC.
Benzoin, powder 10.00 g
Iodoform 10.00 g
Storax (Styrax prepared) 7.50 g
Tolu Balsam 5.00 g
Diethyl Ether 100.00 ml
Group : 12.3.3 Other Dental Preparations
Storage : EHIJdBNAiBW[|\UBPK [}>QHZBgUQg\\ gTWEHIJdB^OE` @IB
Zinc Oxide + Zinc Acetate Powder
Synonyms : Compound Zinc Oxide Cavity Bases
Zinc Acetate 1.00 g
Zinc Oxide Powder q.s. 100.00 g
Group : 12.3.3 Other Dental Preparations
Storage : EHIJdBNAiBW[|\UBPK

2.2 
 YZ [\ 
 


CREAM BASES

Non-ionic Buffered Cream Base

Cetostearyl Alcohol 10.00 g
Cetomacrogol 1000 3.00 g
White Soft Paraffin 10.00 g
Liquid Paraffin 10.00 g
Monobasic Sodium Phosphate 2.50 g
(Sodium Dihydrogen Phosphate)
Citric Acid, Monohydrate 0.50 g

30
 EDTA 0.01 g
Propylene Glycol 5.00 ml
Chlorocresol 0.15 g
Purified Water q.s. 100.00 g
Note : @AFC pH 5-6
OINTMENT BASES

Hydrophilic Ointment Base

Stearyl Alcohol 25.00 g
White Soft Paraffin 25.00 g
Liquid Paraffin 10.00 g
Sodium Lauril Sulfate (Sodium Lauryl Sulfate) 1.00 g
Propylene Glycol 10.00 ml
Paraben Conc 1.00 ml
Purified Water q.s. 100.00 g
PRESERVATIVES

Paraben Conc
Methyl Hydroxybenzoate (Methylparaben) 10.00 g
Propyl Hydroxybenzoate (Propylparaben) 2.00 g
Propylene Glycol q.s. 100.00 ml

31
32
33
74

 3 

 
  


 
    !
  " #
!$ !%& '! 
"()*"% )&(%
 
!+ ,  -+!%
(!
. .!/  )0'$.
()
/ " #%  ")!% 
  .)&(
. "%   1  )12*3 3 )./43 1.(  ".
)  " #".! 5%  ! /&-  312 /()   )
(  *6# ! 4   
  
    .  12 * 3  3/ 5 &   
   /&17) 6 (*6#  
3.1 (*6#!4
 +)%
5% 05
  
3.2 (*6#!4
  )0'$.
  
3.3 (*6#!4
 )/( (&/&(!
$.
  
3.4 (*6#!4
 ) )'%,#/&(! $.

  
3.5 (*6#!4
 
  
3.6 (*6#!4
  )/)2+
  

3.1 

 

 !"!#$%
"&'(

Good Compounding Practice for Non-Sterile Products in Hospitals

  &" 2 .3
(7% ? 1
1. 4) ( /)!+ (Non-sterile Products)
2. 05 (Sterile Products)
 
   .&
(/&-2%! + 0 1!) 1!)
5&7 ".1!)
 3/5  1!)%!)) " # 1!) )".
//2(!(2%) 3/5)  4)
   +)%!%. 
. ( 
53  .+2" (Dosage Form) 5% &5)
,# (Elixir) &"!. "1,   1) 5 (- 

1
 /&  (    )          %   1!)  )   "%  ."(%
 $.
.12*3   X)(*6#!4

 +)%
5% 05
   5%!
( 
  +
 % ()./) .!  .  )/Y".2*# 
5
!Y2 Z[(  )/".- !/1!)1 /3".
!/ 2 (( *&&( Beyond-use Date) 2".^$
".)* , )&( 12   %+
1. @A
1.1  1!  %
!*/..  )()./) )"/ /!% )
Y% 0  )$(% !*% (!*
(1&'"%1+
(!*)12% (( " % ( !* ) 051!
" !* ) 4)( /)!+
1.2 '*.3
 )1 1!12)2*(3) 1!)5".Z2. _ /
`a3  (Z2 %(( - (
%
!* ! +)%1!- ^ ".".% .' (((%
!* 
..&
()Z2 `a
2*#(  5% Z_ %"./ +bb_ ((% 
+)%-Z2 (/(2
(`a
1.3 )% % ) %  1 %  %
(
!*  
5&1!)
/.)%& 
1.4 )./. (   +)%) " &1!)/.
!*!  . &1!)/.%".(  21 ".2!! & 
&1!)/. ".+)%1!&1!)/.
*. 
2.
CD

2.1 12*!2c
2.1.1 3/5 )
27.!553/5)
2.1.2    3/5)(   5% ! 1!0 '. 
)4 )0'd 6  % & (%)3/5   )12*/)".

2
1!)()./) /)Y&(+)() )1!)
".5
 
X+
2.2  3/5) 1!+Z[/ 3/5  %
% Z [/.!
2.2.1 Z[
51 ) 5 5% 1 5 ".1 !
2.2.2 Z[11 3/5) 5% /) (Levigation) 
/) (Trituration) /)" Geometric Dilution
2.2.3 /12*/) 
"% ? ".i  ! 5%
1!)1 !".-'
2.2.4 1&!* 3/5)
!4Z[/ &+   /4 ".Z[X % %  )
/./ .).)Z[X '*.  ".
/ 
2.3 "% 
1!"%   ! /     / . ".)  _    `a  ! !.
%  5% )
( )"." *. !)_  ."%
! !.(%! )".&
"%   
2.3.1
/%/12)/. *
5/1) 1!/!)"!% Y2 )
( ".12) 
2.3.2 )" () . (
 (1% ?
, &
(1!)/ ( %  1!" 3/51!12) )_ 
(
(  "!"%*
2.4 /23)   
2.4.1 (X  . )/23)  ".+!
/23 %  d. 1 1
2.4.2 1!))  !/23) /%!211  $.
 %  (&  )  

3
 2.4.3  /!)52X /.%j%5 ()./) X
!)Y ()!12)) ^ Y2 ) )1!)&
2.4.4 (1% ()"^!*!(  % 
()X  !  ) 
3. D&( &(EF(C#

3/55
&( 5".12*'*. ( &75 5
&/ &(!4
5 "."'1 ) 2*#
5
 

   , &(+!

*6#)k.2 3)". 3) )k
3/5) .! /4*/2
3.1 1 5 1! %
)1!)5& ! .)1 +)%1+(!
% ".(% 5% )() 1!)!/31 5 .&2d
( %

/3 ".)/+!! 
5"! !/1 5

Remingtonms Pharmaceutical Sciences, The United States Pharmacopoeia-The
National Formulary (USP-NF) ( USP DI Volume III: Approved Drug Products and
Legal Requirements 1!!/&(&/2/)Y5 + 1 5 
5 5
&(/)* ? 1!
51 5 +! (Sensitive) Y 5 &(/
&!%1%&/25 + 1!
5!4 Aliquot
5
3.2 1 ! 
51 !  % ()./) 1!
5.! 
%    (  )!%   ) /   !  -     
(    1!)")%  & 
(Accuracy) )/2 ( % ? 1 +)%1!! )/ !% 20%  )
.! Y/() 5% Glycerol (Glycerin) ( Mineral Oil  %
(+(
.!
(() (
5!45  1&!*1!)Y%! &. (Specific Gravity)
 /" Y/ ! )) )
5 Micropipets  !+1!)^
/ Y /)5/)Y! /+.(!% 10 +)1 Y 5 )
.! 1 (Conical Cylinder)
5&! 1!)/.!
/)/
! !  "%)1!)")% & !%.! ".+)%1!
5.! 1)
) !% 25 ).

4
 3.3 2*#/)( )  1!)% 2 .3 1  % "! ". %
Porcelain ( Wedgwood % "!
5// (Stain) () (Oily) ".
5 )/
.3 Antineoplastic Agent /&(% Porcelain )!( !%
5

/)  ( +)%
(.
!*/)  ).'5  %   ) Spatula ( 
(
5
(Spatula -!% 6 !
5/) "( 
(7%!% 6 !
5/)1)( )*
)) ). (Slab ( Tile) /) )2*#()./) 5% ! .'
# "% "!1 +bb_  - "."5%"- 
4. (D#F
(
H(I

4.1. /1)/! /&17 ".! 5%!
4.1.1  )k)&  (Pharmacopoeia)  )(
5
5  )
 1!)/24 (Certificate of Purity) &)! ".,
"(% ,5Y+
4.1.2
*" #+)%.2" (Dosage Form)  
( ) ".

(3/5&( 1!

5/1)
(/1 "   i 
&)
5
"  +"%
. 12*/)  31) ". 3 ! /&17
. " 
(./43/ /2
1. .!! 5%  2 "./3!. ! ()/(+)%)
. '*.1 '
. 1!)/.!

(  ".
5  !
" . )"! ! ?  
. Y/1)
& (! .
" &
5% &
/ &5) ( ,#
. Y/1)
&( 
"  "%
2 (Divided Powders) 5% , ( "1,
1. Y/1)
&  (!". "(  &
/
&"!. ,# ( )5

5
 4.2 .34 (Extended Release ( Delayed Release) +)%1!
&)
5 ! /&17
4.3 $ Y! /&17 $1!!/5  (. 5
 Prodrugs , .+)%4)
(
" 5% .) 1!)1 !
! 
& % ( First Past Effect ".1!)%. Y "( 
5$ 
.! !% 2 ! ./)
5. # 
&()*
"%.1 .)k".1!)) "%.
    !+.)* 

/  ".1!)1 ! Y++1!&
!!1.(# 1)
()
!% )12*3/)&/)".)1!)1 ! ))
 " 5 /(!4 ) 1!&!1.(#,&1 
!1.(#".-+!. .!+)% !%!&(
-
/  % 
6. HL(DF 


)  )
/
(    
   1!!/!%  )    3 * 6# 5   
&(%
 (+)% Y)&(% !!% /
&"%  (+)%
Y!/"!!% 3*6# &(% )/% ? ()./)1
5' 1!)
) /()./) 12*/) 1)  3 "../43
' )
1!)  / % 1!
53*6# 
 

*+)%)3*6#&(%
  1!1& Y
- !Y2./ 1# 
5  , 
5!4" 
- ) / (/!5 .52) (1)
- & +
5 % +
- /3!. !
- . .!
5 
Y&  1!!// % 5Y 1!)+)%1 !
.(!%  ".
.(!% -' Y+)%))1!)1 ! 1!35./5.
(1!)1 !) / 2
3/51!$   .2!/ 2(*&.21!
5%!
".) -' % ()./)/&(1+
6
7.

N

O@D  EF"P  
7.1 1!-))k3/5& ()"&(% ".& 5% -

35.^/ _ "/ )$&.2!4- ".
7.2 -'
 1!)/24 "./&/1)/!53*6#"%.5+!
(k 
5
0''*. /1) ".&&( !-
' 
7.3 1!-')2*(3)&(
(-/1)".!53*6# ?
7.3.1 2*(3)( 1!12) (Controlled Room Temperature) )+ 2
1!)() ,  
5
(()./) 1 1!12)2*(3) 30+2  0,, / 
2*(3 )
5
0'1!)1 /3 &   /%!1!12) 2*(3 )
(  - 
/1)".!53*6# !+() Y 2*(3)
( 0.)* 25  0,, /
(2*(3)( !+ .0+ . %.(!% 23 Y 35  0,, /)
7.3.2 2*(3) - (Refrigerate) . %.(!% 2 Y 8  0,, /
7.3.3 2*(3)5% "- (Freezer) . %.(!% -20 Y -10  0,, /
7.4 /1) 5% ., (Acetone) 1!" -% ( 1!)
3
) !-'/1)".!53*6# (%))+ USP DI
Volume I ". General Notices and Requirements Section ". Section  ! 
USP-NF ".&  ?
8. D D  EFD"L
!( 
8.1 1!)1  ! USP-NF &  (1!)1  !  
  "%  ? +! !%    )
12*/)  3-1)  25!!  )./43
' +)%)1!)' )
1!)1 !)&(-'".&+
5 )12*/)".'*.()
*. ". %1!12)12*3(%! 3
(3   
i ).%1!)1 !  +"% 2*(3) "/ /!% 1!)5
0 231 1!)% 1!)/24 & 12*/) /. 35.
2 `a ".

7
 8.2 1!
5%!. ..... (Beyond-use Date) &(1!
5%!...... 
 . 0 )1!)1 ! /1)&() ("&(%
(  3/ 5 &    ".!/ ! 5  (  3/ 5 3 * 6# /&  -     &  (% 

  Y
53*6# &(% "(%  //&17
 1&!*1!
5
%!. ...!/ 2 3*6# ,) (!41&!*+ USP DI volume I)
 !+&(!1!
5% 
  
5"! ! ?  
. 
5!Y2 5%
5/1)! /&17 USP ". NF
&(
( 1!
5%!. ...+)% 6  !
. 
5 /&- 5% )- ( "1, ! /&17

(&( 1!
5%!.....    . 25  !( % "%+)% 6 
!
1. * ?
() 2%. .!
5
'".+)% 30 !
1!!/'*.% 5Y 1!)+)%1 ! 3*6#  &
!/
.(!%  ".!-'%%
(1+

*   ! +)% 1  ! ".1!)  ) c /  &    +)%  ./
/&-  )
5!4  5% )-  (  "1,/)(
()./) .
(1
"%.)
9. P"F
%C

%C EF
#ST

9.1 35.2

1!35.2()./)"  35."! (/
 )
5) 35."! )
5.+)%&X 
/ +)%  1!)5 % %
^^ ".1+)%" 35."!/5()./&( /)/ + "/ /&(
35./)1!) )
5) .1Y!%".!%35."! 1!
35./ ))k 3/5&
9.1.1 )&(!4&1!)/.()./)
9.1.2 +)%1!&X   1)". 3 )( ,! 

& &
(1!)3 1!)" 12*3 ".1!)/24   " +
&(

8
 9.1.3 /)Y_ /)12*3 1!) "/ /!% ".
0
9.2 2 
9.2.1 &  2
!" ! / 5 _    "/ (  !/   + 
)k
9.2.2 1)(  2
(/(
.2
9.2.3  2
Y2 /),-1+
5
. .!/ ?
9.3 ^$ 1!)$/&( 
   .!
9.3.1 5 ! /&17 , 5/)7 (5 1)
 *
.25 &./  +!$! . )! /&17 ! "%
5&
./ %  5% &5)"/, ) 
5 Syrup USP &./  (
5
&./ & (Sugar-free Vehicle) 
9.3.2 1!)"    %"  ! % 5% &"!
. &())%) 
9.3.3 )*2
9.3.4 
9.3.5 ! ".!/ 2/1!
5%!. .... ( 8.2)
9.3.6 !4-' 
Y
53*6# &(% "(% ) ! /&17
(.25! /&17
5/)7 +)%1!
()51X %$ "1,
(.2)*! /&17
% 1 "1, &.21!)"  //&17% 1 Dose 5% 125 )./5 ). ( 10
)1!!,#/15 ). )#)! /&17 Y&!-) 1!)#$.
&!-) +)%)20 ) 5% 25 )) +)%
5 25.0 )) Y !%&!-)
(
)0 #(20 ) 5% 0.25 ))
$5%! 1!
&"(% (-+5 "./.2 Y35.2-
!%.^+ $".$5%! 
/%1!) $5%!  $".)
1!)
((- % 5

9
10. (
@D
DC
V
EF

3/51!&/ , .! (1) /&".!4 (2)
  . )/
5 (Batch Records) (3)  ! ".
"'1 )/2*#
5
 (4) "(% /1) ".

10.1 /& ".!4 /)2 ("- .! 5".1!)
"  ! /&17".! 
& )*
5 !4 ".&
110' 5%  )/%!/) 5 +)%+ (Aliquot Method) !/ 2 ( 1!

5%!. ..(Beyond-use Date) ".!4-' 

-'1!12)  )&!'! /&17
*
)! /&17)!%( &1!12) )5! /&1725
/.!
1(
10.2  ! .   /)221  )
 . /)YX),&+".) /
5
  ) .  
.  (Lot Number)
. 5 ".1!)" (Strength)
1. "(% ) !Y2 !)  2% (Lot Number) 
5
. )* ".&!(%!  (Dosage Unit)
. 5/5!/ ".1&!*! 
&
$. 5! * /&(! $.
5. " 
,. !
7. !/ 2/1!
5%! . (Beyond-use Date) ".!4-'
10.3 ".'1 )/2*#
5
 1!"'1 )
".2*# )1&".&
1%) % 1% 1
10.4 1!))
5 1+ 
("%
!% )1!)1 !
  3".+)% 1 ".)!

10
11.
D
DC DCP (Quality Control)
11.1 1!12 )12 * 3  /%! (  (  *6#! 4 
  
 !  /2% )!  %   & ( ! 1.(# /   1#  .
/".*2) 
()
!% !Y2 !/2/&(2". +%
!1.(#/)&(
11.2 )51!12)12*3 , )12*/)()./)".)./*#

!/ ". " /.Z 
11.3 &(k 1!12)12*3) 
11.3.1 )1 )2 *#   .& + % ) ./ 43
21+Z[) )(*6#!4

11.3.2 )1%)!41!12)12*3
11.3.3 )!4X+2)"!
 /2%)! % !/
!Y2 35.2 3*6#2 ".3*6#/&-
11.3.4 &!!1.(#)!4!1.(#/&(+!
11.3.5 )/2%)! % !/ ".!1.(#/
11.3.6 )1!12)12*3  ".!Y2
())k
11.3.7 )!/ !1.(#
11.3.8 )&)k!4X (SOP) 1!12)12*3
11.4
*  +)%) (%! !1.(#12*3  1!)&(k
 1!12)12*3) 
11.4.1 )"/% !!Y2".  +  /%!55

!1.(#12*3 (( X315+ )k).

/
11.4.2 )!/
12. (
@(L("

3/5./1/!5% ? +
12.1 )%!/ ! 1)!#    1*.3/5-
0/# ( 
11
 12.2 !/ ( //&
12.2.1 &+"%3/5&% ? 5% Remingtonms Pharmaceutical
Sciences; Martindale: The Extra Phamacopoeia; The USP DI; Handbook of Institutional
Pharmacy Practice ". Thai Pharmacopoeia
12.2.2 ".&+"% Stoklosa and Anselms Pharmaceutical Calculations;
ASHPms Handbook on Extemporaneous Formulations; Canadian Society of Hospital
Pharmacists: Extemporaneous Oral Liquid Dosage Preparations; Pediatric Drug
Formulations: Physiciansm Desk Reference; Contemporary Compounding Column in IS
Pharmacist; AHFS Drug Information ". The Merck Index

12
3.2 

 

 $OTF

Good Compounding Practice for Extemporaneous Products in Hospitals
Extemporaneous Compounding (  )0'$. 1  )
/&(! $. " #
( ) " +)%)&(%
  (+)%
)
     )1!)&3/5 )
 ) 0'/&(
! $. 
(+ )1!)))  " ()./) )1!)1 !
 ))./43
' ".( + % Y
E
 $OTF
"!  ) 0'$. 5.  *(*6#
3/5)Y 
(+ Y " ()./) )1!)1 ! )'*.
 3 /)Y )+ % ".!-! /&171 )./43
'  )
( i  1& Y -1"(%  
5!Y2 1!))  ) 1!)1
! ! /&17 &./ 
5
/& &(!/ 2  35.2
".-'
*/&
 ) 0'$. 5  .) 

5 ) *) " #/ %

(! % 1 .& 1!)&! 1!)1 !
".c/&"% /%!  ))
5)*  +)%) )1
1! 1!&0'11!)/&%5Y//2.
/

c&./ )
5  ) 0'$.


 
% &(
 $OTF
 ) 0'$. )(*6# * 
. 0'"  )
. 1!))()./)%1!)1 !"./.!%( 
(
!
1. 0'i )%1!)1 ! 1)". 3 ! /&17
. 0'c/&()./) 5% c&./ )
5
. 0'.! )Y /.! ".!-!
$. 1!12).! !/+
13
 5. 35.2".-'Y
,. 0'".&(!/ 2  )
. ^$4 !4
5 1&".&

5 
7. *Y 1!)/)Y
(  ! ".. .!
5 
 ) 0'$. 5. 
(+ )1!)1 ! Y
3 )./43
' !)Y )1!)/.!!-!". % % ) 
! +)%
5!
 (%! 3/5)  1!)(*6#% ? 
Y ()./)))c/&&./ )
5 , ) .  
1. $V
O]#E

H(
"  )0'$. 5.) %( " 5% 
 (Trituration) &
/ (Solution) &"!. (Suspension) &"!.
(Emulsion) ". ?   )*"".1!)1 !  )   1)
".  3
()1!)/.!
 )".
5   ) 0'$.

" &5. /%!
(7%) ) %
" &"!.
2. D HL HLH(
 ) 0'$.
" &5. /%!
(7%&
)-) )" & i7( % ( -1 1!))" # /
5
! "%. "%  &
((%! 3/5) )&(1!))
()./) 
( )
"%.1   ))1!))&( "."
(" #
!Y 1!))  )
( 
( % "./.!%/
5 ".% 
!)Y % %&(!/ 2  )
3. $V
O#^%%  !(D D H( @ID _
i )%1!)1 ! 1)". 3 ! /&17 ".1!)1 !
"  ) 5% !Y2
5 1!))  ) &./ 
5 ) 1!)
% 2*(3) 1!)5 "/  ) .  
3.1 "(%  !Y2
& (Brand of Ingredient)
& ( )-  "(% ( '   %  )  )
0'$. .)%1!)1 ! 1)". 3 ,) 3/50/#

14
  )
("% +  "(%  !Y21!"(% )1!)%5 Y ".
 *!/ 2 !Y2!
3.2 1!))  (Drug Concentration)
 ) 0'$.
" &5.)1!))
"%  .) %  . ". / )/  ! "% 
  1!)1 ! 
"%.1!))-.)1!)%    )&(1!)
)()./) 
 )1 %+-1!
51!))&(21
3.3 &./  (Vehicle)
 ) 0'$.
" &5. /%!
(7%. ) %

" &"!. &+

5 +)%-+!   )& &"!
. Deflocculated System "!
5&./ )/5%! "!.
2%)
Structured Vehicle 5%!
"!.
( . ! % /)&/)  ! % 
c/&&./ )
5  /Y/23-"(% 5)(5 , "%
 5 " "%.")12*/)$.!"%  
5&./ "

 %12*/) 1)". 3 ! /&17 (Active Ingredient)

3.4 /5%! "!. (Suspending Agent)

5&./ )/5%! "!.  ()./)12*/) 1)
". 3   .2 1!)1 ! X .(!% /5%! "!.".
1!)()%12*/) +( /5%! "!.% ? )
5 /%!)
+"% Natural Gum 5% Acacia, Tragacanth (/!)# 5% Methyl cellulose,
Carboxymethyl Cellulose Sodium (CMC) 
5 Natural gum )-+!.  )
-+,)# Oxidase &
( /)/ "..).!  52 #+   
5
/)# 5% CMC1500  )
5
1!)) 0.25%-1.5% /",11
+# / 1.(# ).2 . +
& )1!)1 ! pH 3-11 , 1% !
) mucilage ) pH  ".)1!)/.! %
 )  ()./).

5/5%! "!.
 )&./ )
5

15
 3.5 1!)-% (Acidity and Alkalinity)
1!) % i (  /&17) /2%1!)1 !   
1!)) hydroxy ". hydronium ion )% Hydrolysis  ! /&17
 1!0'c/&
() pH ()./)
 Hydrolysis , pH .(!%
5-6  pH ()./) ( 5 /&(/
5 Buffer  pH +"% 25% citric
acid solution ". 0.1M-1M NaOH 
3.6 ,5 (Oxidation)
X ,5)%1!)1 ! ! /&17 / )&
(
,5". (
(
  )
( /2 5% , "/ (.(
!)Y 2*(3)  
 ) 0'$. - *Y / )
/&
1!0(.((/ )% X ,5 5% & 1! Purified
water
/&) Chelating Agent 5% Ethylenediamine tetra-acetic acid
(EDTA), Citric acid )/ Antioxidant 5% Sodium Sulfite, Sodium Bisulfite
( Ascorbic Acid  1!( ,
0 "/ ".2*(3))%
X   ,  5   ) 0'$.  1!2
35. )  ()./)
_ "/ ".-
)2*(3)()./)
3.7 2*(3) (Temperature)
2*(3))%.  ! , .)X  (
/ ! !  %X ) 2-3 %
2 ? 10  0,, /
)+) Arrhenius Equation 1 log k = log A (Ea/2.303 RT)  k : Specific
Reaction Rate, A: Frequency Factor, Ea : Energy of Activation, R : Gas Constant (1.987
Calories/deg/mole), T : Absolute Temperature   1!-  )0'$.

2*(3)()./)
3.8 // (Preservative)
// "%.5.)12*/) 1)"% 
5%! &
( )1!)
1 ! / /
&    pH   ) / / 
5) +" %
Sodium Benzoate 0.05%-0.1% )12*/)
// 
5%! pH 5 (&
!% //  ))5( 1 paraben )12*/)//
5%! pH

16
!  )
5 Methylparaben ". Propylparaben   ) Paraben Concentrate
.! 10% Methylparaben ". 2% Propylparaben .
 Propylene Glycol
 ) 0'$. 5. ). ) &"!.
 +)% )  
51 !)  
.! )  1! ) ! 1 1 )"
5 (Aseptic Technique)  $.  )/&(-"+)%1!
/%//
.'". +
4.
F

 $OTF]#E

'IEHF
(
 )  0'$. 5  . Y  )
 " & "!
. )!4 )"% - )" !Y2! /&17  

)-( 
)-  ( 
( . 
% "! Levigate   % 5 ?
! Levigating Agent &!-   ) Ready-to-use Vehicle /%!(.

( .  % /)&/) ".
(+) 

)-1 (Film Coated Tablet)
 )-1
( . 
% Levigate ! &&!- 
. /%!1)-  "! Levigate ! Ready-to-use Vehicle &!- 
  ) Ready-to-use Vehicle /%!(. ".
(+) 

)-4  ". )-( 
"1,"0'
()&& 
"  )0'$.
5.

%CEF

N

O
 )0'$. 5.
" &"!.1!2
()
!%
! (Headspace in Container)  /&( % 
(+ "%+)%1!)
!%
!()+ , %
0)%1!)1 !  
 35.2
(()./) ".&(
(2
!/5_ "/ ^/
(Tighted-light-resistant Container) %  +)%& -
 - "%1!)"%


 1!)1 ! ! /&17 &(

(-
 - 2*(3) 2 Y 8  0,, /
!Y) Stability Data &(!%  )1!-2*(3)( 20 Y 25  0
,, / 5% &"!. Clindamycin 5.

17
 6.

I @'(C
 /2
 ) 0'$. 1 &(!/ 2 
 11!!!))/!5&% ? +&!1.(#".)#+!
"!//2&(!/ 2  )0'$. 5.
(
&(!/ 2  .*!!% )*! /&17)
1!)" ( !% 90 %  1!)"   &(!/ 2  )0'
$.
" &5.
( (.).!
()1!)/  /2
% +)%)./43
'  
. &(5%! !/ 2/!%(%!/ 2 )/
!5
5//2 1!))

./43'  )
. &(!/ 2+)% 30 ! !/)  ")  5.)
)!5//2!/ 2 !!%-)  )! +  /)
("!

! "%.1 .)^^35. )%1!)1 ! ! /&17+ !

)-' 
 -)2*(3)+)%+)&(".Y- &"!.
 )0'$. +!+."%   (Caking)
&(!/ 2  )!+.
51&!% Expiration Date "%
/&(&  )0'$. ))//2+)%)1!
51&!% Beyond-Use
Date ( 1!
5%........
7.
#ST

$^!  )0'$. 5...25! 5! 

/&17 1!)) ! /&17 !4.  !".%  !/ 2
!4-'". %!%
5 
 ) 0'$. 5.  )
)* 
5

. .!/ "%! &
5 
. .!!% 30 ! ) ) 
 0'$. 1 .) ? 1! !  
( ! +  + . 
(
   
5 1&  ()" # / .i 7 (  /   2 %     !
. 1&(    ) 0'$.
" &5.

'*. Reconstitute 1 "  2 !  !( !/5
/%  %
 "(

18
!/ !2&./ "()./)  )!  
5 
(/)
 "( &./ 
( ,  ".&!  !4/) ".
5 
 " +!
$  .2
(Y !/ 2 ".-'( !/) "!
c/&  )0'/&(! $. 5. )

5)*) 1!&0'! 1!)1 ! ! %  ) 0'$. )

1!)/&17
'".)
5% 1  /Y/23-"(% 5)(5 5%
2%) j%5!*1 2%) 1(!
".1!)(  /%!/&)
5
+)%)1 1!  0'!!)) 
5//21!)1 !  ) 
/%!
(7%&(
(-  )0'$.
 -2*(3) 2 Y 8  0,, /
8. (
@D
DC

 ) 0'$.   )) . +&(+!
/
1!12) "%.5%
/1!12)) . " +! 5%
5  5 1 1!)"  
5  !  Y2  & ! 
5  )  )  )
"  ) 1!)) /&&./ 
5 !4 ) $".&

5  !/ 2 -' ".!!*) (Literature Review) % ?
@C#
 ) 0'$.
" &5.  "
)-
(+ &)1!)))  /  1& Y 1 1!)1 !  )
./43
' 1!)3 ". )..12*3  ) 
 )c/&".!4 ) % % , !)Y c&./ 
)
5 ) 0'$.  c&&./ )
5
()(
" "%.")12*/)$.!% /)Y
5
(()./)12*/) 
"%.5 1!)/.! % !-!% ) + )1!)1 !".)./43

'  1!0'(1!)1 !  ) )/)"!) 2/) 
c/&/)Y'1!)1 ! ! 
()./43
'+!+
 ! /)Y( +1)&(!% / 2 !)Y .( 1%
5%
. 5#
'".1!)3

5 

19
3.3 

   
   
 @((&( I @I 
]L #`  
TF

Good Compounding Practice for Parenteral Nutrition in Hospitals

 )/( (&/&(! $. . X)
(*6#!4 + &(+! 
(
5/( (& +/(
)12*3)k )()./) ".)1!)3

5  
1. @A (Aseptic Section)
1.1 &(
(+))k/Y 05  1!" 
. )  5% Cytotoxic Drug
1.2 *+)%/)Y&
((  )/( (& Clean Room
+ 1!)( /." )//%!
1.3  ) .  )3
 Laminar Air Flow
2.
CD
 (Personnel Sanitary)
2.1 21".(X  )12*/)+)12*/) 21
)/ (*6#!4 
 +)%
5% 05
    2
21
2.2 &  ((   " .1!)    5   (      !     )
/( (&
"%..  '*#' (  )
/( (&  )3/5 %  1 1
2.3
()/".Z[)( !  )/(
(&
115 (Aseptic Technique)  % % )1!)
()./)
3. D&( &(EF(C#
 (Equipments)
3.1 2*#".1 ) %
(  )1!& Stainless Steel (!/2+)%
% /
(/ /% ? `a+
3*6# ".1!)$.&
%
3.2 2*#".1 ) &1!)/.+ % ".+)%/./) Z2 (
51

20
 3.3
()&2 '2*#".1 )% ? ). .!&( ".
+!(k
3.4 )  !/./  4 3  1  )  &    5%  1   0
(Laminar Air Flow)  !1!)-!) (! Plate /`a 
5". +!(k
4. H '(H(
 (Process)
& )/( (& /&(! $.  )
& ( &    %  5  21    !   +  ) ) 
./  % 
/%! " #   3/5 
(+/( )
12*3)k)&(
4.1 )!/ /(
(  (&  . )/& (  !
$.
4.2  !  ) X).!.2+!2
 "
 ? .!  .2+ !  +  2 )    5 
 '*# '
4.3 )!/1!)) 1 ) 1!)Y  !Y2 "./
% ? %21
4.4 1!12)12*3.(!% 
!*  +)%/ %12*3
/( (&
(`a 5+
4.5
.(!%        _  (  $ "/ Y  ! 2  5  
5

.! ) ().&/)Y_ 1!)// ! "%.
5+
4.6 ))()./)
_ `a
.(!% 
4.7 /)/(  )&/).2+!
/&(
4.8 (   ^$
*+)%/)Y&+  )!4
()./)(_ //(^$
4.9 ! 25)"%
5  ).2! ! ^
5 &( 2 +!
$ ".-
/3!.()./)

21
 4.10 )1!12)12*3!Y2
- /335.2 ".((%
- !/ 2
- Clarity Test
5. (
@ (Document)
//%!/&17 ..12*3 ,  /1 (*6#
! 4   
 )/(
(   (  &   ) 2  ./ 1#    &  (
 .  !  "!
X  ".1!)

X    /)Y!/)
 )
*% ( )
i7(




5.1 /& +1!)(-5 5%
5.2 / )1!)5 " ".& % 5

(!/+ %
5.3 1!)!2 /
(/)  %/)


  

- Standard Operating Procedure (SOP)
- Batch Production Report
- $

22
3.4 

 

  O!(d@I
]L#`TF


Good Compounding Practice for Cytotoxic Drugs in Hospitals
(  *6# ! 4   
 )  ) ' %  ,# /& (    ! $.

   .!1!12)"..12*3 //  )'% 
( ).- ,  )/&(! $.
 ) )'%,# (Cytotoxic Drug) . )(%! 5 $.
/Y   )  )  .1!12 ) 1!)/.3
(  ".._    
"%. . /%3  /&(.! ) 
5115
(Aseptic Technique)  .!   ) 3
 Laminar Air Flow Hood
5 Vertical _ `a (Contamination) ".1!)3   )
1. @A (Aseptic Section)
1!" /Y ) )'%,# !* ) 
1.1 1!12).0
1!" .0/Y ( )  ?  -

!* )   1!12 )1!) 0
(" %     !* )  %
()./)  /%!* )  X  ".!/2/  % ? 1!%"#-
(Air Lock) 0% /%!* ) 1! % Prefilter ". HEPA Filter !)
0".0Y()2! )
5 1! ./77*
*
.1!)0/ ".1!)!/.1!)0"../77*
. . ? )+!(k
*+)%/)Y&
((  )  Clean Room +  %  . )(
" )//%! )1 0 (Air Condition) ()2! 0
(
 )  "."'1!)/.
(  ) . & /)&/) 
(+
(  ) /./2
1.2 !* ) 
 )   &3
!*_  %X     )
3
 Laminar Air Flow Biological Safety Cabinets (Class II ( Class III)
23
2.
CD
 (Personal Sanitary)
2.1 /2) /%!211
2.1.1 X  )/23 ())3!.-! /)13#
& . 13# (
()2 X  !  )  %! )()2! 
( )  %  2 6 
2.1.2 X ".  )5) . /!)2*#_ !
) .2 + !
 !* X   "%  ."(%  2 *# _  
5 + " % "!%    3
52X _  Y2 ) !) 2*#5%! (

2.1.3 ()/!)52X !* ) 
2.1.4 X +)%1!
51 /& "./!)1 . *.X 
2.1.5 () .(  1 ! &) /2( (-
(+!3
!* ) 
2.1.6
(X))k% ? &(+! % 1% 1
2.2 !/23
2.2.1 Baseline Examination 1%. )! Baseline +"% 
! (CBC), ! Biochemistry 5% Liver Function Test, Urea, Creatinine,
Electrolyte ".! Urinalysis
2.2.2 Routine Examination ! ( X,& , 
!.&+
5" 21)) 1% Baseline  21(%
. ( &  !  1)& !%!/,&.!% 
!/%3!. 1!& Routine Examination  %  2 6  ".)-)
!+!
 Medical Record  21"%.
2.3 )
21 !  )".(  )'%,#  +Z[)
11()./) 21 %!.! 3/5 0'3/50/# ".21
Z 115%!  ) X   21 !  .).!  
2.3.1 X)
/ )  )'%,#

24
 2.3.2 !4X

  (Worksheet) ".! /
5

. /) 
2.3.3 X /%X 
!*( /.
(Clean Room)
2.3.4 &  Laminar Air Flow
2.3.5 &1!)/. ".& . )'%,#  %
".( .! ) "5 (Aseptic Procedure)
2.3.6 -'"./%  )1)&
 1!).)1!)".1!)/)Y X . . ?
".+!(k
3. D&( &(EF(C#
 (Equipments)
3.1 1 )".2*#
5
1 )".2*#% ? 
5
!* ) )'%,# 1!" +!

!* %!% ".+)%1!&+
5
!* )  ? Y&
52*#,
!+
5
!* )  ? . &1!)/.2*# %  &
4 `a%.1  !* %!
3.1.1 Syringe ".522*# ) 1)& !) 522*#

(  1!" Luer-lock _ ( /   Syringe 5.)
'*. !, . Lock -)
3.1.2 -)
5/. 1!
5-))
(7% (# 18 ( 20) 5%!
1!)/
" / ?
 Syringe -)# )

5 ) 1)& 
1 -)) +)%-!%# 21g/1.8 mm
3.1.3 2*#
5 ) 1)& 1!"
5"! (/
, 1! (  ) /- ( () 1)&(
3.1.4 1!! Plastic-backed Paper Liner ! Biological Safety
Cabinet (BSC) 
5 )  _  1)&( BSC ".1!  Plastic-
backed Paper Liner (  ) /-"%.! ()) 1)&(
3.1.5 +)%1!2 
 Syringe
())*2 Syringe

25
 3.1.6  )/-"!1!2
35." Zip Lock ".$!%

3.1.7 1!)35. /) 5% Y /)Z^ !"!
)Z^ (Y(.)Z^ 1! )2*# %!+!
 BSC %)X 
3.1.8 Syringe !&".! 1)&  1!$ 5 !
(! 5    ) () !4( /-!
(  !/!
 ) !/ 2 ".!4-'(   +)%Y
5
3.1.9 Syringe !& ".! 1)& 1!$
(!%
 1)&.!
3.2 2*#
5/&(X  (Containment Equipment)
&!/&  1 Biological Safety Cabinet (2*# ?

5/&(X )+)&(% *1  2*#++!
!*
1!&/./43 1 %
5 
()% 1!&!/./43
 1  %  d. 1 1
3.3 HEPA Filter
 HEPA Filter
" Bay-in Bay-out , /)YY  "%
 /+  "% ".%/ +)%/)/ 03  Y+)%
/)Y HEPA Fiter
" %! 1!Y "% / %
.).! ".-+!
Y2 / ( ^Y2 /"!
(
/%Y2 /
5( ".^5% ! ". $Y2 / ^"! .2 1)
&  )1!)!% &+&   2*(3)/
4. H '(H(
 (Process)

 ) )'%,#. Y  ".X %+
1) !%! /23".1!)3
2) 1!12)!/ 5%  
(! !%()./)(+)%  ) 
Y  )5  ./% /Y ) +  ! !% +)%)
`a (Contamination) (!,) (Leak)
.(!% /% 
3) !4&  % 3 ! 11Y% /5 "%.1

26
 4) /( (Spillage) ". . (Disposal)
 ) 1)&
5115 (Aseptic Technique) 
(!
+3*6#)12*3 5 11  _ /)/   ) +!
5. HL(DF 
  (Precaution)
5.1 !4X) (
.  521 )2(2 %! ".  %

!* %!
(() ".&1!)/.!* %!
5.1.1 )*  * &Y)(&!-  5-
("( !
,)+ 5% ( Y  &!-
(5-! d ((
d  ".1!5-&1!)/.!* ( %  3 1
5.1.2 )* ) 
5.',( 5((),
& + "!5-&1!)/.!* %!! & &1!)/. "!)! &
/. !/2
5&1!)/.`a  () !!)
/%Y2 ".&+&  
&2*(3)/
5.2 !4X)+/)/ 

*X/)/  +)%!%.% Y2 )(52X  /!)
/% (
/)/  !*( (.-  X ) 
5.2.1 YY2 )(52X /!)
/%
5.2.2  !( /%!/)/!  ! &)*) ? Y/)Y
5
/. &
( (Neutralizing Solution) + -
(
5 !( /%!/)/! 
5.2.3  !( /%!/)/! ! /%".&
5.2.4
* 
( ! &)*) ?
5.2.5 /%
(" #!
2  1     (2  *#  %  ! .      +!    (  k".    +!

!5.  X !

27
6.
% 
N
 O!(d
6.1 " - "%.5 "..2!*-
(5
6.2 )-3 ". -
(()./) ( "(
!,) ! 
7.
H@!
7.1    )" ! .    - 
35. %     _    " ! ( 
`a
*./% +  (!
7.2  ^$1!) 1)& .).!
8.

I% HF##ef( O!(d
 .`a )'%,# ".!/2% ? )`a  -
35.
^ /  , & 1  () "/ !%  /1)     .&    35.^  / 
 %! &  2*(3)/ 1,800-2,100 F ( 1000-1,200 C
9. g@I
#h
  (Standard Operating Procedure)
1!  & )k/&  ( ! 4  X       '*#   '   _    +)%
(
X/)/!  )k/&(!4X 1!& 5%
9.1 - Stock 
9.2 ./%
/ (Order) 1)&
9.3 .! ) 1)&
9.4 /!)52X ) 1)&
9.5 &1!)/.(  ) 1)&
9.6 /% 1)&
9.7 &1!)/.)35.2) "(`a) ".
&  !  ".!/2`a!  %!
9.8 &1!)/.2*#  ) ".5/%!% ? 
5
9.9 !4X)(2
9.10 &2 '1 )
9.11 - (  )
9.12 11 )  

28
3.5 

 



Good Compounding Practice for Ophthalmic Products in Hospitals
 )  3/5
    )3*6#05

* +)%)&(%
  3*6#(%
5 (  ($

(5% Intracameral) ". %
/. & "!. (
/ /&17
 ) 
   +"% 1!)05 , ._ 
5"./7/ 1!)/)Y
) (- `a5

.(!%   ) 1!)Y 
1& !*". )  (  
Subconjunctival ($ ).)5%!  '"1 ()1!)
 % 2"
11 )/. 
5
" !"! &
( )1!)) 
) 2 %1!))   (++1!/ ,3*6# 
+27. & 
(
  
("%
!% 05 )1!)
1 ! ".1!)+ 
(*6#!4
  
  %+"! 3/51!
&+X )&  )3*6# 
   "%+)%/)Y&)
5
&(".1!12)12*3
  2/()
1. %
5/1)
 )  3/51!!/
()
1!)/)Y&)
5&( 3*6#.(   Y+)%)/
(
) 3/5 0 1!)5&7
 3/5)
.)1!)()./)
3*6# /&((  %
2. i /&17
/
 )3*6# .!
1) 1!)05
2) Tonicity
3) pH, Buffer
4) 1!)' 
5) 1!) 
5//
6) 1!)/)Y
.
7) 1!)1 !
&./ ()./)
29
 8) 1!)(
9) 2((% ".-'3*6#
3. )/"/ /&(/)/%!. /1) "%.5 ".
-
+ % !4 ). "/  . 2 !) 110
5 ". 5 (&
(05
/2 5% Autoclave
4. %) )3*6#  1!!1&!* !/
2 1 1  ( 
5 ! 4  
1&  !*  1!)  
( )    /2  ! 4   )
1!)/&17/&(  5% $
 , ) 
5 ". 
( 1 1!)
.0 )
 )3*6#(%&
(
)) % 2"
5.  ) 
)*)./)Y5 ! +Y 1!),
1!)+)%")% &5 ! !
)* ? "% .! /)
( 
+ % /)&/)  $. ) 
6.  Y115(&
(05 % 1% 1  
/%!/&17  )   )3*6# . &
 Laminar Air Flow
(( Isolator ( Biological Safety Cabinet, BSC)  )  )Z[('.
".)1!)5 !57
 )  X)(1!12)12*3  ) 
05
   ".&( 1!)Y
.!2

 )3*6# 1!)* 
(1)
 )  1!/)/% ?
35.%05 /.
"%.51!
/%
 Syringe "   1%
/%!)
 Syringe 
(7%!% , )
 .2/%!/) ()+  / -)+
 Syringe
(7%+)%
)-) %
(2) 1!)Y
5 ! 1!.
5 syringe -/2
2
)/%!/)  Y+)%)) +)%1!.&..)*)
(5% Y ) 4.5 ml
 Syringe  5 ml "%+)%) 4.5) 1!
5
Syringe 2 ))5"

30
 (3)
5-)". Syringe 5 Disposable  1!
51  !"!
2
( `a"._ 1!)/(1
(4) Y & ( 1 1!. $ (Label) +!35.2
5!1!! _ //
(5)
 )   Sterile Powder  &). &%
5 (
 (! Ampule 1!&/%!/) ()) % Filter  5 &0'
% ?
7.
*  ) 
(05 1!!4&
(05
".!/1!)Y     ! 4  & 
(  05     12 * /)   
3*6# ".35.2 !4&
(05 ) 1  % Filter 
0.22 m 
35.2/2 Y&
(05"!  % +-)!4+)%()./)
 )'*. &"!.".  ) ) /%!/)  +)%+
&
(05. &3*6#/2 )&
(05%.&+
5
! &
(05 Autoclave 3*6# 
35.2/2 "%
*!%3*6#)1!)1 !( % Autoclave (+)% ".. )1!12)
12*3.(!%  ) ()./)
8. +)%1!
5//
&$+
 (Intraocular Injection) .
//  5)'%1 / 3

9.
 )  Cytotoxic Agents (/  ? 3/5.
(1!)3
& /1)(%
10. 35./2 2  )1!)()./) ".+)%1!.)%1!)
1  ! "../  4 3   ( 5  /)Y2
!/   & 
(
05"!  5)2/&(( 
!(52(( "  
5 1!.Y2
(/&(2 &
(05"! 5$
+)%+
5(  )/- 1!.2
 Sterile Vials )!%.2
 Syringe
35.2 % 1!.)^_ `a
11. 3/51!.&(!/ 2   ))1!)1 !
3*6#".1!)++ `a 2 # !  1!)1 ! 1)

31
 /%!/) // ".35.2 1!&)* .)1!)1 !
3*6#  ()
12. $  ) 5".Y
 *$  ).
.2&( 1!)) //&17".// ! $-1!..2!4-
 Handling ".!/ 2
(5 . 
  $ %
(! 
( % 
(/1 
HL(DDIVAV
 @F
i  !  )/.  ) %+
1. 1!)
/ (Clarity)
 0Z2 ") 
5!4 
(
/ ()/&
(
/
(Clarifying Agents)  5 5% 1% Polysorbate 20 ( 1% Polysorbate 80
2. Tonicity
&/. Isotonic  % 0.9% Sodium Chloride Solution  % +
-) 1!)) /)Y+ 
% 5%! 0.6%-1.8% /)) # Sodium Chloride 
 5 Hypertonic  )! 
)*/  Hypotonic 1!)
/ + tonicity
(+)  /%!
(7% )
5 Sodium Chloride, Boric Acid
( Dextrose 1!)%  1 300 mOsm/L ( %
5%! 200 Y 600 mOsm/L)
3. pH/Buffering
1!
5/1!)%
)*  
(& pH /%/3!.
( ( "!  !+1!
5) Buffering Capacity  !% 0.05
1% pH ()./)/&( 1 4-8
4. 1!)05 (Sterility)
/. &
(05+ % ?   ! Sterile Membrane
2 0.45 ( 0.2 +)1 !4 ? 1 Dry Heat, Autoclave ( Gas Sterilization
(Ethylene Oxide)
5. / (Preservation)

5( ? 1 1!)// )1!)()./) ". +
//&17
&

32
 6. /,5 (Antioxidation)
   ) /  ,  5 
  3 * 6#    ) 1!)1  !
(   
/,5
5
  5% 0.1% Ethylenediaminetetraacetic acid (EDTA), 0.1%
Sodium bisulfite, 0.1% Sodium Metabisulfite ". 0.1% Thiourea 
7. /)1!)( (Viscosity Enhancers)
)1!)(.&
(/. 1  %
+ ). .!
(! 
 ,) + ! 1!)(    % .)* 25-50 cps ". .   1
/
( 
/%/)1!)("! /)1!)(
5 0.25% Methylcellulose 4000,
0.5-1% Hydroxypropyl Methylcellulose ( 0.5-1% Polyvinyl Alcohol
8. 2 (Packaging)
1!2/. 
!)(( 05("% 2 
"%. Dose
 Syringe 05".+)%)-)

33
3.6 

 
  
 %
@ C 

Good Compounding Practice for Herbal Products in Hospitals
/)2+!Y2.0+ +  1!. &c/)2+
  
5             .0+ ".2  1  
% .0 ).)*!%1". % ? 5%    b_   + -1
1!( (% ))1%  &
d 2542 .)* 5000  ". 1!)
 "!  % ? ) ) /)2+
" &! Mixtures  %
"! , /%!
(7%"! (% .)'*. Low Dose ". Large Volume    )
/)2+
    +)%
5%  (++)%+ .i2) 
/)2+( 5 %
75 ("(% 5    /)1!  % ? 1!)
 )  )/)2+ 
75 ("(% 5
g
%
@ C
3*6#/)2+%  "i2 , ). )// 1.(#
 $.11".!4 3*6# /)2+ )!Y2+5 ,
).)) `a )1!)"%
 - ! "( - !
" , )%12*3  
/%! ./43".'*.3 
   / /&17)/2  ) /)2+ 1 "12*3
!Y2)+".!".1!12)12*3
1. @A
1.1 !*-
!Y2/)2+1!)" -
!*$. ). 0 %  )
_ /!#".")  $./!#)bi".  )!/)./43
+)%
()  ! 25) %
!Y2/)2+  )

/%0'

1!)/. 1/Y-'!Y2".!* ?  $.Z2. /%!
&(
-//  # /1) /%!.
&  35.2 ".
$  )/)2+ )/&-"! )&(5% ! ) !+
+)%
5% 05

34
 1.2 !*&
5% ! !+   )"&1!)/.".( 
`aZ2. 1!.! 0'.(!% /2%)! % 5 &( /) ".
.! /)2+ .! Z2. ".`a
2.
CD

 )1!)1!)5&7 ".X!5% !21

 )  )!+ "% ))  /)2+)) 1
2.1 


 : 21
(%! 1!12)12*3  )1!)5&7

 !Y2/)2+/3*6#/)2+ /)Y!/'*# !/`a
% /  /+)%/)&/) !Y2/)2+ )1!)
&)k/)2+
 
5
   ".      '*.3
 3    '*.3
   
20#".1)bbd
2.2   : /2%)! %  21)1!)5&7/)2+
/2%)! %
(X)".&
 WHO Quality Control Methods for Medicinal
Plants Material 1992
3. D&( &(EF(C#

"  ) Y %
" & 1)   1+)#(
  ,  .
5  1  )  5%  !  )  ! + "% Y  ( ) "1, ( 
. )1 ))) "%.   "%)(" -'
2*#5% !  )!+ /&171 /."."(
4.
% /%   AC
 @ C
4.1 &1%)
 )!Y2"%.5 ))k".-
 ! 5%  2- !  (   ((% Y /%.!
 )/+!  2.!".!4./% %12*3 
& &+!/) !) "(%  . & .
".- ! )1!)& %   5 )* ".!&- !
5 ? !) /1)"./ ? 
5.(!% . 5% 2 j%")
4.2 - !21  )$&".)

35
 4.3 !Y2%  Y./)!)  ).!%   /)
 ! 
/) )/ !
4.4  .(!% !Y2/)2+"., .  '*# '/)
5% +!
/&(12*3 /   )
) !3)0/#( /30(/!#!
5%!  - !
+!!
4.5
(0'"%( (  ! 5/)2+ +)%!%.5%!
. (
.!
()1 !)
12*/)% ?  /)2+".


11X 
5. HL(EFI
 %
@ C
5.1 1"(% "./)2+)1!)/&17 % )  1
 %  +)%1!,!Y2/)2+"(% +)% %  1!,
'*. Contract
Farming 1!12)12*3 ".! "

5.2 /Y-!Y2/)2+ /. ?
5.3 +)%1!,!Y2/)2+-+!! +)%&
5.4 /)2+ 5) 5% ).)_) ) 12  ! "

,
6. (
@
6.1 12*'*.) !Y2
 )&( !Y2&)& /)2+ .2
/ 
- 5'0/#
-  . "(% ) 5
- !4&
("( "."
- '*.3  !Y2/)2+('*.3
 20#
- !'*#()./) 1!!//./&17 %
"! (!/ Markers ( TLC Finger Print

36
 - !1.(#!Y2))k Thai Herbal Pharmacopoeia (
Pharmacopoeia  % .05Y+ Y+)%) &)k /)2+"%.
5+!
6.2 &( 3*6#/&-
!/
51!12)3*6#/&-
()/4)&( 

5 12*3".5 )* Y/4
(!1.(#)*/4 Y+)%

(!1.(# Markers " (1!12)12*3 ()*// (extractives)

!
&. (solvent) 5% ? !'*# %  1!& TLC Finger Print 
!Y2/)2+".3*6#
*+)%//&17 /&(&( ?
(+)
)k 
" ? 5% Y &!+
53
)&( 2 #

)*%
-
( Y)
6.3 1%).! 1!12)12*3 /1!)1 /3 ".
/2%)! %
1!) 1% )  5       ) ! 4  X   5  2      )  .2
 1# .% ? 5% 1 ) !/2 !4  % . 
"% .! Y2 /)2 +( 
3*6# ".)X 21  )/1!12) ". 
5% !  )!+
7. DI$  (Glossary)
Markers () Y /% !. /)2 + , ! % 5".
5
1!12 )
)k /)2+  !+ Marker ./))*)(!1.(#+ % ".)
1!)/)4#//&174 /)2+ ?  //&17))* ()!4
!1.(# 2% 
5 Markers .)12*3 !Y2(3*6#/&-+ 
5
Marker % )*

37
38
39
74


1. 

 
  2543.   . . 2542 ( "
#$
).
&'(: *
+#
+ 
& ,
-
&' $'". / 1-48.
2. + & 
. 
23.
#
454&67 
&
& ,&8
5
#9 #:;&/< 
. =
#

&=#
. 2545; 9(3):249-258.
3. =/ &/= +, + & 
. 
A ,==:&
& ,3.:=
  furosemide. =
#
&;#

*
 . 2540; 8(1):31-40.
4. =;"
 = +-L =
. 


#.
 &/< &< 5*
 &/< . =
#
#&;#

*
  (-
&' $'), . . 2535 -M'7 2 8  '7 2 : 60-64.
5. =;"
 = +-L =
. O6 
-P  &;#

 #9 #:;&/< 


 
'+
'
=#Q
#:, 2541.
6. American Society of Hospital Pharmacists. ASHP Guidelines on Preventing
Medication Errors in Hospitals. Am J Hosp Pharm 1993; 50 : 305-14.
7. American Society of Hospital Pharmacists. ASHP Technical Assistance Bulletin on
Bulk Compounding Nonsterile Products in Pharmacies. Am J Hosp Pharm.1994; 51 :
1441-8.
8. ASHP Guidelines on Pharmacy-Prepared Ophthalmic Products.
9. Compounding Ophthalmic Liquids. Secundum Artem, Volume 6, No. 4. (Available
online at www.paddocklabs.com).
10. Connors KA, Amidon GL, Stella VJ. Chemical Stability of Pharmaceuticals : A
Handbook of Pharmacists. 2nd ed New York : Wiley 1986.
11. Quality Control Methods for Medicinal Materials.1998 (viii+115 page).
12. Szkutnik AJ : Extemporaneous Formulations and Quality Assurance in Handbook of
Institutional Pharmacy Practice. Thomas R Browned. 3rd ed : American Society of
Hospital Pharmacists. 1992; 237 z 245.
13. The United States Pharmacopeia, 22nd rev, and The National Formulary, 17 ed.
Rockville. MD : The United Sates Pharmacopeial Convention 1989.
14. USP DI Volume l : Drug Information for the Health Care Professional. 14th ed.
Rockville. MD : The United States Pharmacopoeial Convention 1994.

1
74

 

  

 (Compounding Card)

Phosphate Mixture
[Inorganic phosphate (Pi)  30.4 mg/ml]
Dibasic sodium phosphate (Na2HPO4) 13.6 g
85% Phosphoric acid 5.88 g
Purified water to 100 ml
'()

(
1. 1213 dibasic sodium phosphate 45567
2. 48 85% phosphoric acid
3. 9: pH :;93 pH meter <=4>;?:; pH 4.9 :;93 85% phosphoric acid
A7=3BCD1EA?:;<F5356748 ?GGB8B GB pH 4.9, 1725 mmol/L KLCMN2GB inorganic phosphate
 30.4 mg/ml 4O;35B6P345 30 95 Q3Q9:R54O; S?9;45AT;3S5-ORMV==G:

1

*+,
-./
0 120)/34
)

( )

( /)56)7/-


895<=2R 8TA=A7=567=2833W=;RG4O;
1 2 3 4 5
CMC Mucilage* 15% 15% 10%
70% Sorbitol 10% 20% 10% 10%
Glycerol (Glycerin) 5% 15% 5% 5% 2%-3%
Citric Acid adjust pH pH 5-6 pH 5-6 pH 5-6 pH5-6
Paraben Concentrate 1% 1% 1% 1%
Bubble Gum Flavor 0.3%
Spirit Peppermint 0.3%
Purified Water 5% q.s.to 100% 5% q.s.to 100%
Simple Syrup q.s.to 100% q.s.to 100% q.s.to 100%
Storage temperature cool temp. cool temp. cool temp. cool temp. (freshlyPrepared)
Beyond-use date 3 months 3 months 3 months 3 months

*Carboxymethyl Cellulose Sodium mucilage GB8TA=A7=:M5B6

CMC 1500 1.5%
Paraben Concentrate 1.5%
Purified Water q.s. 100 %

2

 )80 80*
9:; *+,
-.; <(4)3120 *.*+ ;-'(
)=

6 8)

( /)56)7/-


Generic name
9:;   2*B*+, CDE9   

)

( )80 80* 
-. (C) (*)
(mg/ml)
 F)23+ CG

Isonizid (INH) Suspension 10 2 2-8 21
Pyrazinamide Suspension 40 1 2-8 30
Rifampicin Suspension 50 4 2-8 30
Ethambutol Suspension 50 1 2-8 30
 G
D1H
Amiodarone Suspension 5 4 2-8 30
Captopril Suspension 1 1 2-8 7
Hydralazine Suspension 2 2 2i8 7
Hydrochlorothiazide Suspension 10 3 2i8 14
(HCTZ)
Propranolol Suspension 2 3 2-8 30
Verapamil Suspension 10 1 2-8 30

3

.
:I*).(<(41201*


OmCR n9GQ;GQ;5BC4O; n9G n9G?GQ;5

(O9Mn9GQ;GQ;5BC4O;) Q;GQ;5
8TM8o:*
Chlorobutanol 0.5
Quaternary Ammonium Soaps,anionic
Compounds materials,
saliclates,nitrates
Benzalkonium chloride 0.01% (0.004-0.02%)
Benzethonium chloride 0.013
Organic Mercurial (0.001-0.01%) Certain halides with
phenylmercuric
acetate
Phenylmercuric acetate 0.004
Phenylmercuric nitrate 0.004
Thimerosal 0.01
Parahydroxybenzoates 0.1 Absorption by
macromolecules

* n9GQ;GQ;58TM8o:87>=3ABC4O;8GD85m6R3mCRQRMAr:3A=M?G4O87>= ocular
devices O5 nR5n158s

4
234.
234
0 234/0* D
3.*:
- 8.
) (1*
,
 

234.
234
0 234/0* (Synonym) D
3.*:
-
Glyceryl Stearate and PEG-100 Aracel 165
Stearate
Carbomer 940 Carbopol 940
Cetomacrogol 1000 Polyethylene Glycol-(20)-cetyl Ether; Ceteth-20
Cetrimide Cetavlon, Hexadecyl-trimethyl-ammonium
Hydroxide
CMC 1500 Carboxymethylcellulose 1500
Cocamide DEA Cocamide Diethanolamide; Coconut
Diethanolamide
EDTA Ethylenediaminetetraacetate
PEG (O5 PEG 400, PEG 1500) Polyethylene Glycol
Polysorbate 80 Tween 80, Polyoxyethylene-(20)-sorbitan
Monooleate
Sodium CMC Sodium Carboxymethycellulose
Sodium Lauryl Ether Sulfate Sodium Laureth Sulfate

5
;D80 9B0*)<*;-
)

( 1*G
/ 
(extemporaneous compounding)
1. ASHP's Compounding Resource Center QRM American Society of Health-System
Pharmacists http://www.ashp.org/SterileCpd
2. International Academy of Compounding Pharmacists www.iacprx.org
3. International Journal of Pharmaceutical Compounding www.ijpc.com
1mRA=M editorial topics N2GB>9Q;R4>;1mRv1;9N2?:;OmCR=mCRMBC=2o9R3T459=8=w?>5
4. MICROMEDEX ] CCIS (A;RMQR4O;=E=QRMG>9E313BC<F58GOE) 48OmCR3v1;91mRBC
drug evaluations
5. The National Home Infusion Association http://www.nhianet.org/index.cfm
6. Pharmacy Times http://www.pharmacytimes.com/compounding.cfm
7. The Practice of Pharmacy Compounding http://www.fda.gov/cder/pharmcomp/default.htm
8. Professional Compounding Centers of America, Inc www.pccarx.com (wW28GOE)
9. Secundum Artem Online i Paddock Laboratories http://www.paddocklabs.com/compounding.html
10. Compounding Hotline- Pharmacy Times
11. CompoundingToday.com- Formulations (1M2B354O;x=B 30 95)
http://compoundingtoday.com/Formulas/SearchByTopic.cfm?CatID=9
12. RPhWorld.com-Pharmacistms Online Resourses http://www.rphworld.com/index.php
GB>9Q;R4>;1mRGG3 895BCBC39M5D1EAN2GB>9Q;R Compounding & IV Ad v12 Parenteral
Therapy 1mRQ;?<N2GBQ;R3R3RB>1>13
13. The Hospital for Sick children-Manufacturing
http://www.sickkids.ca/pharmacy/section.asp?s=Manufacturing&sID=7232
GB8TA=3 extemporaneous 87>=:S
14. IARC Monographs on the Evaluation of Carcinogenic Ricks to Human
http://monographs.iarc.fr/ENG/Classification/index.php N:1oG8=nGBBCRN<F58=RG2=SM
15. Color Additives QRM US Food and Drug Administration http://www.cfsan.fda.gov/~dms/col-toc.html
16. Ingredients Prohibited and Restricted by FDA Regulations http://www.cfsan.fda.gov/~dms/cos-210.html
17. 59*p80 9
q*

;-) (ECrp 
  /6
18. ).
80 9 :BE) (ECrp (Material Safety Data Sheet, MSDs) P8O=n9==T;Nv>1MQ;RGT1
BC39 MSDs KLCMGBR3TGG3 http://msds.pcd.go.th/name.asp

6
 (875)
n78CMn}2R5o==G=W~5OB3>1v>MOAE
BC 4/2548
=mCRM vAMA6Mn}27M5N:7P8OA7=r=MW31

WmCR4>;=<=<=oMOB3>1v>MOAE<F5?<R3M>G28G <F5=2 v12GB<=28EVEPW

NLMGBn78CM:M5B6
Q;R 1. 4>;vAMA6Mn}27M5QL65Oo:>5LCM=B39 n}27M5N:7P8OA7=r=MW31
Q;R 2. 4>;n}27M5AGQ;R 1 GBRMns<=2Rv12>5;BC:M5B6
1. no}>EMEWW= 8EA<=BO <=2V5
2. P.EAAE WEs5EAE55s =RM<=2V5
3. P.G5A=B 8o9}EO3s r=MW31E=E=O DT;7M5
4. P.11EA N12 r=MW31=O9EB DT;7M5
5. P.95E: :O95s 858oQPW:Sv>MOAE DT;7M5
6. P.8oW =rGo r=MW31W=2<=2v:M DT;7M5
7. P.}W= 8o:8oQ 85r=nDE9>5M DT;7M5
8. P.NEAAsV:E  OTv8M1E9ENEA= r=MW31No1M=}s DT;7M5
9. P.5P:1 8GG RMns=P8O==G DT;7M5
10. P.8oPP=}s <AEW= r=MW31N;W=23RP3PT= DT;7M5
11. P.8o=8EVE 9O=28oQrWVE r=MW31QR5v5 DT;7M5
12. P.RE5E= R:E r=MW31G>=O5n==O8BG DT;7M5
13. P.5EPW= o==sWMs r=MW31OB3M=3<=2O5on=2>s DT;7M5
14. =.:=.9=P=}s N==3<=28=E n}2P8O8A=s G>9E313G>E:1 DT;7M5
15. P.WO=B E=E :E r=MW31w2OEM= DT; 7M5
16. P.<=2?W NRME=E1E 875W~5=2=E=8oQPW DT;7M5v121Q5o=
17. P.9=5:: =B8oW==} 875W~5=2=E=8oQPW DT;7M5v12DT;O931Q5o=

7
>5;BCQRMn}27M5GB:M5B6
1. W~5v59nE:v12>1=45=n:1mR3N8Go5?W===No45OB3>1
v>MOAE
2. W~5}s45=n:1mR3N8Go5?W===No45OB3>1v>MOAE
3. n:1mR=3=3N8Go5?W===No45OB3>1v>MOAE AG}s45Q;R 2
4. N:7=312RB3:Q;RGT1M9EO=QRM3N8Go5?W=BC?:;==n:1mR
5. RmC5 AGBC?:;=GR>G3

6M5B6A6MvA:5B6<F5A;5?<

8CM } 95BC 14 =nG W.. 2548

(1MOmCR) N=8 8o9==}91
(8A=N=3s53vW3s N=8 8o9==}91)
<=2V5n}2R5o==G=W~5OB3>1v>MOAE

8
9
74